_unit_id,_created_at,_canary,_id,_started_at,_channel,_trust,_worker_id,_country,_region,_city,_ip,direction,b1,b2,direction_gold,e1,e2,relation,relex_relcos,sent_id,sentence,term1,term2,twrex
503007609,7/14/2014 20:41:48,,1323086615,7/14/2014 20:41:27,elite,0.875,28503042,USA,NJ,Woodbridge,54.191.150.115,APL treats DIC,79,3,,81,6,treats,0.657595949221429,902646-FS1-2,"In APL with the translocation t(15;17), all  trans  retinoic acid corrects the DIC in 2 to 5 days; combined with daunorubicin or idarubicin, this regimen can induce remission in 80 to 90% of patients, and long term survival in 65 to 70%.",DIC,APL,RO-disease_may_have_finding
503007609,7/14/2014 21:17:02,,1323104362,7/14/2014 21:16:29,prodege,0.7639,28255346,GBR,L9,Sheffield,2.125.183.137,APL treats DIC,79,3,,81,6,treats,0.657595949221429,902646-FS1-2,"In APL with the translocation t(15;17), all  trans  retinoic acid corrects the DIC in 2 to 5 days; combined with daunorubicin or idarubicin, this regimen can induce remission in 80 to 90% of patients, and long term survival in 65 to 70%.",DIC,APL,RO-disease_may_have_finding
503007609,7/14/2014 21:30:53,,1323111225,7/14/2014 21:30:27,neodev,0.7333,18755947,GBR,H2,Accrington,80.47.185.52,no_relation,79,3,,81,6,treats,0.657595949221429,902646-FS1-2,"In APL with the translocation t(15;17), all  trans  retinoic acid corrects the DIC in 2 to 5 days; combined with daunorubicin or idarubicin, this regimen can induce remission in 80 to 90% of patients, and long term survival in 65 to 70%.",DIC,APL,RO-disease_may_have_finding
503007609,7/14/2014 21:44:31,,1323120250,7/14/2014 21:44:03,instagc,0.6292,21551272,GBR,E6,Chipping Campden,78.145.193.123,APL treats DIC,79,3,,81,6,treats,0.657595949221429,902646-FS1-2,"In APL with the translocation t(15;17), all  trans  retinoic acid corrects the DIC in 2 to 5 days; combined with daunorubicin or idarubicin, this regimen can induce remission in 80 to 90% of patients, and long term survival in 65 to 70%.",DIC,APL,RO-disease_may_have_finding
503007609,7/14/2014 22:29:28,,1323145771,7/14/2014 22:29:01,instagc,0.5867,23149109,USA,NC,Durham,75.189.206.205,APL treats DIC,79,3,,81,6,treats,0.657595949221429,902646-FS1-2,"In APL with the translocation t(15;17), all  trans  retinoic acid corrects the DIC in 2 to 5 days; combined with daunorubicin or idarubicin, this regimen can induce remission in 80 to 90% of patients, and long term survival in 65 to 70%.",DIC,APL,RO-disease_may_have_finding
503007609,7/14/2014 22:32:26,,1323147080,7/14/2014 22:32:21,clixsense,0.3016,25419319,GBR,H8,Liverpool,94.4.192.228,DIC treats APL,79,3,,81,6,treats,0.657595949221429,902646-FS1-2,"In APL with the translocation t(15;17), all  trans  retinoic acid corrects the DIC in 2 to 5 days; combined with daunorubicin or idarubicin, this regimen can induce remission in 80 to 90% of patients, and long term survival in 65 to 70%.",DIC,APL,RO-disease_may_have_finding
503007609,7/14/2014 22:51:26,,1323154584,7/14/2014 22:50:51,instagc,0.6238,19686223,CAN,BC,Surrey,184.65.16.6,APL treats DIC,79,3,,81,6,treats,0.657595949221429,902646-FS1-2,"In APL with the translocation t(15;17), all  trans  retinoic acid corrects the DIC in 2 to 5 days; combined with daunorubicin or idarubicin, this regimen can induce remission in 80 to 90% of patients, and long term survival in 65 to 70%.",DIC,APL,RO-disease_may_have_finding
503007610,7/14/2014 20:33:44,,1323082570,7/14/2014 20:33:23,neodev,0.9583,21515166,NLD,11,Nootdorp,83.86.58.179,CUTANEOUS PHOTOSENSITIVITY causes PORPHYRIA CUTANEA TARDA,34,89,,59,112,causes,1,906439-FS1-4,The mutual clinical symptom was a CUTANEOUS PHOTOSENSITIVITY which is a major symptom in PORPHYRIA CUTANEA TARDA and a facultative one in porphyria variegata.,CUTANEOUS PHOTOSENSITIVITY,PORPHYRIA CUTANEA TARDA,RO-has_manifestation
503007610,7/14/2014 20:45:42,,1323088473,7/14/2014 20:45:21,instagc,0.6111,25990856,USA,NV,Las Vegas,68.108.98.78,PORPHYRIA CUTANEA TARDA causes CUTANEOUS PHOTOSENSITIVITY,34,89,,59,112,causes,1,906439-FS1-4,The mutual clinical symptom was a CUTANEOUS PHOTOSENSITIVITY which is a major symptom in PORPHYRIA CUTANEA TARDA and a facultative one in porphyria variegata.,CUTANEOUS PHOTOSENSITIVITY,PORPHYRIA CUTANEA TARDA,RO-has_manifestation
503007610,7/14/2014 21:12:35,,1323102348,7/14/2014 21:12:15,elite,0.8694,28276268,USA,MI,Taylor,67.149.247.166,CUTANEOUS PHOTOSENSITIVITY causes PORPHYRIA CUTANEA TARDA,34,89,,59,112,causes,1,906439-FS1-4,The mutual clinical symptom was a CUTANEOUS PHOTOSENSITIVITY which is a major symptom in PORPHYRIA CUTANEA TARDA and a facultative one in porphyria variegata.,CUTANEOUS PHOTOSENSITIVITY,PORPHYRIA CUTANEA TARDA,RO-has_manifestation
503007610,7/14/2014 21:23:49,,1323107334,7/14/2014 21:23:38,clixsense,0.5625,16827630,GBR,A7,Birmingham,86.146.169.103,PORPHYRIA CUTANEA TARDA causes CUTANEOUS PHOTOSENSITIVITY,34,89,,59,112,causes,1,906439-FS1-4,The mutual clinical symptom was a CUTANEOUS PHOTOSENSITIVITY which is a major symptom in PORPHYRIA CUTANEA TARDA and a facultative one in porphyria variegata.,CUTANEOUS PHOTOSENSITIVITY,PORPHYRIA CUTANEA TARDA,RO-has_manifestation
503007610,7/14/2014 21:31:38,,1323111638,7/14/2014 21:31:09,tremorgames,0.5903,28013393,USA,CA,Rancho Cordova,71.197.67.37,PORPHYRIA CUTANEA TARDA causes CUTANEOUS PHOTOSENSITIVITY,34,89,,59,112,causes,1,906439-FS1-4,The mutual clinical symptom was a CUTANEOUS PHOTOSENSITIVITY which is a major symptom in PORPHYRIA CUTANEA TARDA and a facultative one in porphyria variegata.,CUTANEOUS PHOTOSENSITIVITY,PORPHYRIA CUTANEA TARDA,RO-has_manifestation
503007610,7/14/2014 21:37:05,,1323114558,7/14/2014 21:36:41,clixsense,0.5974,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,34,89,,59,112,causes,1,906439-FS1-4,The mutual clinical symptom was a CUTANEOUS PHOTOSENSITIVITY which is a major symptom in PORPHYRIA CUTANEA TARDA and a facultative one in porphyria variegata.,CUTANEOUS PHOTOSENSITIVITY,PORPHYRIA CUTANEA TARDA,RO-has_manifestation
503007610,7/14/2014 22:27:26,,1323144949,7/14/2014 22:26:40,clixsense,0.5752,15189335,GBR,K3,Peterborough,81.156.166.189,PORPHYRIA CUTANEA TARDA causes CUTANEOUS PHOTOSENSITIVITY,34,89,,59,112,causes,1,906439-FS1-4,The mutual clinical symptom was a CUTANEOUS PHOTOSENSITIVITY which is a major symptom in PORPHYRIA CUTANEA TARDA and a facultative one in porphyria variegata.,CUTANEOUS PHOTOSENSITIVITY,PORPHYRIA CUTANEA TARDA,RO-has_manifestation
503007611,7/14/2014 21:12:13,,1323102227,7/14/2014 21:11:28,elite,0.8694,28276268,USA,MI,Taylor,67.149.247.166,HUMAN IMMUNODEFICIENCY VIRUS diagnosed by HUMAN IMMUNODEFICIENCY VIRUS (HIV),49,49,,82,77,diagnosed by,0.348155311911396,903805-FS1-13,Ten patients were positive for antibodies to the HUMAN IMMUNODEFICIENCY VIRUS (HIV three were negative for antibodies to the HUMAN IMMUNODEFICIENCY VIRUS and ten refused testing.,HUMAN IMMUNODEFICIENCY VIRUS (HIV),HUMAN IMMUNODEFICIENCY VIRUS,RO-has_causative_agent
503007611,7/14/2014 21:31:15,,1323111416,7/14/2014 21:30:45,instagc,0.6498,19602039,USA,WA,Bellevue,50.135.214.140,no_relation,49,49,,82,77,diagnosed by,0.348155311911396,903805-FS1-13,Ten patients were positive for antibodies to the HUMAN IMMUNODEFICIENCY VIRUS (HIV three were negative for antibodies to the HUMAN IMMUNODEFICIENCY VIRUS and ten refused testing.,HUMAN IMMUNODEFICIENCY VIRUS (HIV),HUMAN IMMUNODEFICIENCY VIRUS,RO-has_causative_agent
503007611,7/14/2014 21:37:47,,1323115011,7/14/2014 21:37:41,clixsense,0.4925,19162475,GBR,M3,Frome,82.33.126.30,HUMAN IMMUNODEFICIENCY VIRUS diagnosed by HUMAN IMMUNODEFICIENCY VIRUS (HIV),49,49,,82,77,diagnosed by,0.348155311911396,903805-FS1-13,Ten patients were positive for antibodies to the HUMAN IMMUNODEFICIENCY VIRUS (HIV three were negative for antibodies to the HUMAN IMMUNODEFICIENCY VIRUS and ten refused testing.,HUMAN IMMUNODEFICIENCY VIRUS (HIV),HUMAN IMMUNODEFICIENCY VIRUS,RO-has_causative_agent
503007611,7/14/2014 21:43:59,,1323119786,7/14/2014 21:43:11,neodev,0.6153,27597779,CAN,AB,Calgary,72.29.251.209,no_relation,49,49,,82,77,diagnosed by,0.348155311911396,903805-FS1-13,Ten patients were positive for antibodies to the HUMAN IMMUNODEFICIENCY VIRUS (HIV three were negative for antibodies to the HUMAN IMMUNODEFICIENCY VIRUS and ten refused testing.,HUMAN IMMUNODEFICIENCY VIRUS (HIV),HUMAN IMMUNODEFICIENCY VIRUS,RO-has_causative_agent
503007611,7/14/2014 22:08:43,,1323133157,7/14/2014 22:08:27,instagc,0.5915,18960682,GBR,"","",86.29.147.112,no_relation,49,49,,82,77,diagnosed by,0.348155311911396,903805-FS1-13,Ten patients were positive for antibodies to the HUMAN IMMUNODEFICIENCY VIRUS (HIV three were negative for antibodies to the HUMAN IMMUNODEFICIENCY VIRUS and ten refused testing.,HUMAN IMMUNODEFICIENCY VIRUS (HIV),HUMAN IMMUNODEFICIENCY VIRUS,RO-has_causative_agent
503007611,7/14/2014 22:31:13,,1323146517,7/14/2014 22:30:48,instagc,0.5867,23149109,USA,NC,Durham,75.189.206.205,no_relation,49,49,,82,77,diagnosed by,0.348155311911396,903805-FS1-13,Ten patients were positive for antibodies to the HUMAN IMMUNODEFICIENCY VIRUS (HIV three were negative for antibodies to the HUMAN IMMUNODEFICIENCY VIRUS and ten refused testing.,HUMAN IMMUNODEFICIENCY VIRUS (HIV),HUMAN IMMUNODEFICIENCY VIRUS,RO-has_causative_agent
503007611,7/14/2014 22:32:20,,1323147019,7/14/2014 22:32:15,clixsense,0.3016,25419319,GBR,H8,Liverpool,94.4.192.228,HUMAN IMMUNODEFICIENCY VIRUS (HIV) diagnosed by HUMAN IMMUNODEFICIENCY VIRUS,49,49,,82,77,diagnosed by,0.348155311911396,903805-FS1-13,Ten patients were positive for antibodies to the HUMAN IMMUNODEFICIENCY VIRUS (HIV three were negative for antibodies to the HUMAN IMMUNODEFICIENCY VIRUS and ten refused testing.,HUMAN IMMUNODEFICIENCY VIRUS (HIV),HUMAN IMMUNODEFICIENCY VIRUS,RO-has_causative_agent
503007612,7/14/2014 21:38:56,,1323115791,7/14/2014 21:38:33,instagc,0.7958,28301350,GBR,K4,Plymouth,92.28.215.248,DIETHYLENETRIAMINEPENTAACETIC ACID treats TUMORS,175,95,,180,129,treats,0.925820099772551,906990-FS1-2,Antibodies modified on the oligosaccharides with either a peptide labeled with iodine 125 or a DIETHYLENETRIAMINEPENTAACETIC ACID chelate with indium 111 localize into target TUMORS more efficiently than the same antibody radiolabeled on either tyrosines or lysines.,TUMORS,DIETHYLENETRIAMINEPENTAACETIC ACID,RO-may_diagnose
503007612,7/14/2014 21:55:54,,1323126297,7/14/2014 21:54:59,neodev,0.1667,11087793,GBR,K6,Southsea,82.24.115.185,no_relation,175,95,,180,129,treats,0.925820099772551,906990-FS1-2,Antibodies modified on the oligosaccharides with either a peptide labeled with iodine 125 or a DIETHYLENETRIAMINEPENTAACETIC ACID chelate with indium 111 localize into target TUMORS more efficiently than the same antibody radiolabeled on either tyrosines or lysines.,TUMORS,DIETHYLENETRIAMINEPENTAACETIC ACID,RO-may_diagnose
503007612,7/14/2014 22:08:07,,1323132824,7/14/2014 22:07:51,instagc,0.5915,18960682,GBR,"","",86.29.147.112,DIETHYLENETRIAMINEPENTAACETIC ACID treats TUMORS,175,95,,180,129,treats,0.925820099772551,906990-FS1-2,Antibodies modified on the oligosaccharides with either a peptide labeled with iodine 125 or a DIETHYLENETRIAMINEPENTAACETIC ACID chelate with indium 111 localize into target TUMORS more efficiently than the same antibody radiolabeled on either tyrosines or lysines.,TUMORS,DIETHYLENETRIAMINEPENTAACETIC ACID,RO-may_diagnose
503007612,7/14/2014 22:27:26,,1323144943,7/14/2014 22:26:40,clixsense,0.5752,15189335,GBR,K3,Peterborough,81.156.166.189,DIETHYLENETRIAMINEPENTAACETIC ACID treats TUMORS,175,95,,180,129,treats,0.925820099772551,906990-FS1-2,Antibodies modified on the oligosaccharides with either a peptide labeled with iodine 125 or a DIETHYLENETRIAMINEPENTAACETIC ACID chelate with indium 111 localize into target TUMORS more efficiently than the same antibody radiolabeled on either tyrosines or lysines.,TUMORS,DIETHYLENETRIAMINEPENTAACETIC ACID,RO-may_diagnose
503007612,7/14/2014 22:31:39,,1323146685,7/14/2014 22:31:14,instagc,0.5867,23149109,USA,NC,Durham,75.189.206.205,DIETHYLENETRIAMINEPENTAACETIC ACID treats TUMORS,175,95,,180,129,treats,0.925820099772551,906990-FS1-2,Antibodies modified on the oligosaccharides with either a peptide labeled with iodine 125 or a DIETHYLENETRIAMINEPENTAACETIC ACID chelate with indium 111 localize into target TUMORS more efficiently than the same antibody radiolabeled on either tyrosines or lysines.,TUMORS,DIETHYLENETRIAMINEPENTAACETIC ACID,RO-may_diagnose
503007612,7/14/2014 22:51:26,,1323154583,7/14/2014 22:50:51,instagc,0.6238,19686223,CAN,BC,Surrey,184.65.16.6,DIETHYLENETRIAMINEPENTAACETIC ACID treats TUMORS,175,95,,180,129,treats,0.925820099772551,906990-FS1-2,Antibodies modified on the oligosaccharides with either a peptide labeled with iodine 125 or a DIETHYLENETRIAMINEPENTAACETIC ACID chelate with indium 111 localize into target TUMORS more efficiently than the same antibody radiolabeled on either tyrosines or lysines.,TUMORS,DIETHYLENETRIAMINEPENTAACETIC ACID,RO-may_diagnose
503007612,7/14/2014 22:53:13,,1323155368,7/14/2014 22:52:45,prodege,0.8333,1852770,USA,TX,Abilene,76.198.102.54,DIETHYLENETRIAMINEPENTAACETIC ACID treats TUMORS,175,95,,180,129,treats,0.925820099772551,906990-FS1-2,Antibodies modified on the oligosaccharides with either a peptide labeled with iodine 125 or a DIETHYLENETRIAMINEPENTAACETIC ACID chelate with indium 111 localize into target TUMORS more efficiently than the same antibody radiolabeled on either tyrosines or lysines.,TUMORS,DIETHYLENETRIAMINEPENTAACETIC ACID,RO-may_diagnose
503007613,7/14/2014 20:43:23,,1323087353,7/14/2014 20:42:57,elite,0.875,28503042,USA,NJ,Woodbridge,54.191.150.115,ACETAMINOPHEN treats PAIN,81,32,,84,45,treats,0.993883734673619,907827-FS1-2,"She is given a prescription for ACETAMINOPHEN with codeine to take as needed for PAIN the week before surgery, and she is instructed to take her atenolol the morning of surgery with a sip of water.",PAIN,ACETAMINOPHEN,RO-may_treat
503007613,7/14/2014 20:45:46,,1323088552,7/14/2014 20:45:43,instagc,0.6111,25990856,USA,NV,Las Vegas,68.108.98.78,PAIN treats ACETAMINOPHEN,81,32,,84,45,treats,0.993883734673619,907827-FS1-2,"She is given a prescription for ACETAMINOPHEN with codeine to take as needed for PAIN the week before surgery, and she is instructed to take her atenolol the morning of surgery with a sip of water.",PAIN,ACETAMINOPHEN,RO-may_treat
503007613,7/14/2014 21:17:02,,1323104361,7/14/2014 21:16:29,prodege,0.7639,28255346,GBR,L9,Sheffield,2.125.183.137,ACETAMINOPHEN treats PAIN,81,32,,84,45,treats,0.993883734673619,907827-FS1-2,"She is given a prescription for ACETAMINOPHEN with codeine to take as needed for PAIN the week before surgery, and she is instructed to take her atenolol the morning of surgery with a sip of water.",PAIN,ACETAMINOPHEN,RO-may_treat
503007613,7/14/2014 21:27:11,,1323109129,7/14/2014 21:27:03,prodege,0.7306,23541832,USA,AZ,Tempe,149.169.129.225,ACETAMINOPHEN treats PAIN,81,32,,84,45,treats,0.993883734673619,907827-FS1-2,"She is given a prescription for ACETAMINOPHEN with codeine to take as needed for PAIN the week before surgery, and she is instructed to take her atenolol the morning of surgery with a sip of water.",PAIN,ACETAMINOPHEN,RO-may_treat
503007613,7/14/2014 21:36:19,,1323114180,7/14/2014 21:35:54,clixsense,0.5974,19803139,NLD,06,Veldhoven,212.61.84.196,ACETAMINOPHEN treats PAIN,81,32,,84,45,treats,0.993883734673619,907827-FS1-2,"She is given a prescription for ACETAMINOPHEN with codeine to take as needed for PAIN the week before surgery, and she is instructed to take her atenolol the morning of surgery with a sip of water.",PAIN,ACETAMINOPHEN,RO-may_treat
503007613,7/14/2014 22:29:28,,1323145773,7/14/2014 22:29:01,instagc,0.5867,23149109,USA,NC,Durham,75.189.206.205,ACETAMINOPHEN treats PAIN,81,32,,84,45,treats,0.993883734673619,907827-FS1-2,"She is given a prescription for ACETAMINOPHEN with codeine to take as needed for PAIN the week before surgery, and she is instructed to take her atenolol the morning of surgery with a sip of water.",PAIN,ACETAMINOPHEN,RO-may_treat
503007613,7/14/2014 22:32:08,,1323146951,7/14/2014 22:32:03,clixsense,0.3016,25419319,GBR,H8,Liverpool,94.4.192.228,PAIN treats ACETAMINOPHEN,81,32,,84,45,treats,0.993883734673619,907827-FS1-2,"She is given a prescription for ACETAMINOPHEN with codeine to take as needed for PAIN the week before surgery, and she is instructed to take her atenolol the morning of surgery with a sip of water.",PAIN,ACETAMINOPHEN,RO-may_treat
503007614,7/14/2014 20:32:47,,1323082083,7/14/2014 20:32:15,clixsense,0.9583,27871219,NLD,07,Amsterdam,87.210.207.223,ERGONOVINE treats VARIANT ANGINA,26,192,,39,202,treats,0.914991421995628,906708-FS1-2,"However, in patients with VARIANT ANGINA a small dose of ergonovine produced a percentage of change in diameter of 39.8 +/  15.3% at the site of spastic occlusion included by a larger dose of ERGONOVINE, compared with that of 7.0 +/  11.9% in the remaining non spastic coronary arteries (p less than 0.05.",VARIANT ANGINA,ERGONOVINE,RO-may_diagnose
503007614,7/14/2014 20:43:45,,1323087606,7/14/2014 20:43:24,elite,0.875,28503042,USA,NJ,Woodbridge,54.191.150.115,ERGONOVINE treats VARIANT ANGINA,26,192,,39,202,treats,0.914991421995628,906708-FS1-2,"However, in patients with VARIANT ANGINA a small dose of ergonovine produced a percentage of change in diameter of 39.8 +/  15.3% at the site of spastic occlusion included by a larger dose of ERGONOVINE, compared with that of 7.0 +/  11.9% in the remaining non spastic coronary arteries (p less than 0.05.",VARIANT ANGINA,ERGONOVINE,RO-may_diagnose
503007614,7/14/2014 21:33:22,,1323112520,7/14/2014 21:33:09,neodev,0.7333,18755947,GBR,H2,Accrington,80.47.185.52,ERGONOVINE treats VARIANT ANGINA,26,192,,39,202,treats,0.914991421995628,906708-FS1-2,"However, in patients with VARIANT ANGINA a small dose of ergonovine produced a percentage of change in diameter of 39.8 +/  15.3% at the site of spastic occlusion included by a larger dose of ERGONOVINE, compared with that of 7.0 +/  11.9% in the remaining non spastic coronary arteries (p less than 0.05.",VARIANT ANGINA,ERGONOVINE,RO-may_diagnose
503007614,7/14/2014 21:37:05,,1323114559,7/14/2014 21:36:41,clixsense,0.5974,19803139,NLD,06,Veldhoven,212.61.84.196,VARIANT ANGINA treats ERGONOVINE,26,192,,39,202,treats,0.914991421995628,906708-FS1-2,"However, in patients with VARIANT ANGINA a small dose of ergonovine produced a percentage of change in diameter of 39.8 +/  15.3% at the site of spastic occlusion included by a larger dose of ERGONOVINE, compared with that of 7.0 +/  11.9% in the remaining non spastic coronary arteries (p less than 0.05.",VARIANT ANGINA,ERGONOVINE,RO-may_diagnose
503007614,7/14/2014 21:39:33,,1323116227,7/14/2014 21:39:13,instagc,0.7958,28301350,GBR,K4,Plymouth,92.28.215.248,ERGONOVINE treats VARIANT ANGINA,26,192,,39,202,treats,0.914991421995628,906708-FS1-2,"However, in patients with VARIANT ANGINA a small dose of ergonovine produced a percentage of change in diameter of 39.8 +/  15.3% at the site of spastic occlusion included by a larger dose of ERGONOVINE, compared with that of 7.0 +/  11.9% in the remaining non spastic coronary arteries (p less than 0.05.",VARIANT ANGINA,ERGONOVINE,RO-may_diagnose
503007614,7/14/2014 21:43:11,,1323119168,7/14/2014 21:42:45,neodev,0.6153,27597779,CAN,AB,Calgary,72.29.251.209,ERGONOVINE treats VARIANT ANGINA,26,192,,39,202,treats,0.914991421995628,906708-FS1-2,"However, in patients with VARIANT ANGINA a small dose of ergonovine produced a percentage of change in diameter of 39.8 +/  15.3% at the site of spastic occlusion included by a larger dose of ERGONOVINE, compared with that of 7.0 +/  11.9% in the remaining non spastic coronary arteries (p less than 0.05.",VARIANT ANGINA,ERGONOVINE,RO-may_diagnose
503007614,7/14/2014 22:32:02,,1323146849,7/14/2014 22:31:26,clixsense,0.3016,25419319,GBR,H8,Liverpool,94.4.192.228,VARIANT ANGINA treats ERGONOVINE,26,192,,39,202,treats,0.914991421995628,906708-FS1-2,"However, in patients with VARIANT ANGINA a small dose of ergonovine produced a percentage of change in diameter of 39.8 +/  15.3% at the site of spastic occlusion included by a larger dose of ERGONOVINE, compared with that of 7.0 +/  11.9% in the remaining non spastic coronary arteries (p less than 0.05.",VARIANT ANGINA,ERGONOVINE,RO-may_diagnose
503007615,7/14/2014 20:33:05,,1323082232,7/14/2014 20:32:48,clixsense,0.9583,27871219,NLD,07,Amsterdam,87.210.207.223,DEFERIPRONE AND DEFEROXAMINE (DFO) treats MYOCARDIAL IRON OVERLOAD,134,77,,157,111,treats,1,907233-FS1-2,"Regarding iron chelation treatment, patients receiving combined therapy with DEFERIPRONE AND DEFEROXAMINE (DFO) significantly reduced MYOCARDIAL IRON OVERLOAD during the 4 yr study period, whilst patients in monotherapy with DFO showed a significant increase in LIC.",MYOCARDIAL IRON OVERLOAD,DEFERIPRONE AND DEFEROXAMINE (DFO),RO-may_prevent
503007615,7/14/2014 20:34:46,,1323083033,7/14/2014 20:34:31,neodev,0.9583,21515166,NLD,11,Nootdorp,83.86.58.179,DEFERIPRONE AND DEFEROXAMINE (DFO) treats MYOCARDIAL IRON OVERLOAD,134,77,,157,111,treats,1,907233-FS1-2,"Regarding iron chelation treatment, patients receiving combined therapy with DEFERIPRONE AND DEFEROXAMINE (DFO) significantly reduced MYOCARDIAL IRON OVERLOAD during the 4 yr study period, whilst patients in monotherapy with DFO showed a significant increase in LIC.",MYOCARDIAL IRON OVERLOAD,DEFERIPRONE AND DEFEROXAMINE (DFO),RO-may_prevent
503007615,7/14/2014 20:48:20,,1323089843,7/14/2014 20:47:54,zoombucks,0.875,28232452,USA,NC,Cary,174.97.217.113,DEFERIPRONE AND DEFEROXAMINE (DFO) treats MYOCARDIAL IRON OVERLOAD,134,77,,157,111,treats,1,907233-FS1-2,"Regarding iron chelation treatment, patients receiving combined therapy with DEFERIPRONE AND DEFEROXAMINE (DFO) significantly reduced MYOCARDIAL IRON OVERLOAD during the 4 yr study period, whilst patients in monotherapy with DFO showed a significant increase in LIC.",MYOCARDIAL IRON OVERLOAD,DEFERIPRONE AND DEFEROXAMINE (DFO),RO-may_prevent
503007615,7/14/2014 21:14:11,,1323103026,7/14/2014 21:13:49,elite,0.8694,28276268,USA,MI,Taylor,67.149.247.166,DEFERIPRONE AND DEFEROXAMINE (DFO) treats MYOCARDIAL IRON OVERLOAD,134,77,,157,111,treats,1,907233-FS1-2,"Regarding iron chelation treatment, patients receiving combined therapy with DEFERIPRONE AND DEFEROXAMINE (DFO) significantly reduced MYOCARDIAL IRON OVERLOAD during the 4 yr study period, whilst patients in monotherapy with DFO showed a significant increase in LIC.",MYOCARDIAL IRON OVERLOAD,DEFERIPRONE AND DEFEROXAMINE (DFO),RO-may_prevent
503007615,7/14/2014 21:40:55,,1323117316,7/14/2014 21:40:18,instagc,0.7958,28301350,GBR,K4,Plymouth,92.28.215.248,DEFERIPRONE AND DEFEROXAMINE (DFO) treats MYOCARDIAL IRON OVERLOAD,134,77,,157,111,treats,1,907233-FS1-2,"Regarding iron chelation treatment, patients receiving combined therapy with DEFERIPRONE AND DEFEROXAMINE (DFO) significantly reduced MYOCARDIAL IRON OVERLOAD during the 4 yr study period, whilst patients in monotherapy with DFO showed a significant increase in LIC.",MYOCARDIAL IRON OVERLOAD,DEFERIPRONE AND DEFEROXAMINE (DFO),RO-may_prevent
503007615,7/14/2014 21:51:43,,1323124746,7/14/2014 21:51:01,clixsense,0.5155,26889820,GBR,C3,Shelford,92.18.120.203,no_relation,134,77,,157,111,treats,1,907233-FS1-2,"Regarding iron chelation treatment, patients receiving combined therapy with DEFERIPRONE AND DEFEROXAMINE (DFO) significantly reduced MYOCARDIAL IRON OVERLOAD during the 4 yr study period, whilst patients in monotherapy with DFO showed a significant increase in LIC.",MYOCARDIAL IRON OVERLOAD,DEFERIPRONE AND DEFEROXAMINE (DFO),RO-may_prevent
503007615,7/14/2014 22:07:31,,1323132443,7/14/2014 22:07:17,instagc,0.5915,18960682,GBR,"","",86.29.147.112,DEFERIPRONE AND DEFEROXAMINE (DFO) treats MYOCARDIAL IRON OVERLOAD,134,77,,157,111,treats,1,907233-FS1-2,"Regarding iron chelation treatment, patients receiving combined therapy with DEFERIPRONE AND DEFEROXAMINE (DFO) significantly reduced MYOCARDIAL IRON OVERLOAD during the 4 yr study period, whilst patients in monotherapy with DFO showed a significant increase in LIC.",MYOCARDIAL IRON OVERLOAD,DEFERIPRONE AND DEFEROXAMINE (DFO),RO-may_prevent
503007616,7/14/2014 20:35:14,,1323083256,7/14/2014 20:34:47,neodev,0.9583,21515166,NLD,11,Nootdorp,83.86.58.179,PROMETHAZINE causes VOMITING,82,147,,89,159,causes,0.308606699924184,907661-FS1-4,"Prochlorperazine was more effective than promethazine in uncomplicated nausea and VOMITING in the emergency department  Keywords: Prochlorperazine PROMETHAZINE Treatment, emergency.",VOMITING,PROMETHAZINE,RO-may_treat
503007616,7/14/2014 21:30:43,,1323111116,7/14/2014 21:30:07,instagc,0.6498,19602039,USA,WA,Bellevue,50.135.214.140,no_relation,82,147,,89,159,causes,0.308606699924184,907661-FS1-4,"Prochlorperazine was more effective than promethazine in uncomplicated nausea and VOMITING in the emergency department  Keywords: Prochlorperazine PROMETHAZINE Treatment, emergency.",VOMITING,PROMETHAZINE,RO-may_treat
503007616,7/14/2014 21:32:44,,1323112188,7/14/2014 21:32:22,tremorgames,0.5903,28013393,USA,CA,Rancho Cordova,71.197.67.37,PROMETHAZINE causes VOMITING,82,147,,89,159,causes,0.308606699924184,907661-FS1-4,"Prochlorperazine was more effective than promethazine in uncomplicated nausea and VOMITING in the emergency department  Keywords: Prochlorperazine PROMETHAZINE Treatment, emergency.",VOMITING,PROMETHAZINE,RO-may_treat
503007616,7/14/2014 21:34:22,,1323113084,7/14/2014 21:33:23,neodev,0.7333,18755947,GBR,H2,Accrington,80.47.185.52,no_relation,82,147,,89,159,causes,0.308606699924184,907661-FS1-4,"Prochlorperazine was more effective than promethazine in uncomplicated nausea and VOMITING in the emergency department  Keywords: Prochlorperazine PROMETHAZINE Treatment, emergency.",VOMITING,PROMETHAZINE,RO-may_treat
503007616,7/14/2014 21:37:40,,1323114957,7/14/2014 21:37:35,clixsense,0.4925,19162475,GBR,M3,Frome,82.33.126.30,VOMITING causes PROMETHAZINE,82,147,,89,159,causes,0.308606699924184,907661-FS1-4,"Prochlorperazine was more effective than promethazine in uncomplicated nausea and VOMITING in the emergency department  Keywords: Prochlorperazine PROMETHAZINE Treatment, emergency.",VOMITING,PROMETHAZINE,RO-may_treat
503007616,7/14/2014 21:45:10,,1323120760,7/14/2014 21:45:03,prodege,0.5819,2143114,CAN,BC,Vancouver,24.84.160.12,PROMETHAZINE causes VOMITING,82,147,,89,159,causes,0.308606699924184,907661-FS1-4,"Prochlorperazine was more effective than promethazine in uncomplicated nausea and VOMITING in the emergency department  Keywords: Prochlorperazine PROMETHAZINE Treatment, emergency.",VOMITING,PROMETHAZINE,RO-may_treat
503007616,7/14/2014 22:29:18,,1323145692,7/14/2014 22:28:30,clixsense,0.5752,15189335,GBR,K3,Peterborough,81.156.166.189,no_relation,82,147,,89,159,causes,0.308606699924184,907661-FS1-4,"Prochlorperazine was more effective than promethazine in uncomplicated nausea and VOMITING in the emergency department  Keywords: Prochlorperazine PROMETHAZINE Treatment, emergency.",VOMITING,PROMETHAZINE,RO-may_treat
503007617,7/14/2014 21:11:23,,1323101801,7/14/2014 21:10:37,elite,0.8694,28276268,USA,MI,Taylor,67.149.247.166,DISSECTION OF AORTA is location of AORTA,51,37,,55,56,is location of,0.960768922830523,905375-FS1-9,Cjest computerized tomography showed DISSECTION OF AORTA from ascending to descendig aorta and hemorrhage around ascending AORTA.,AORTA,DISSECTION OF AORTA,RO-has_finding_site
503007617,7/14/2014 21:15:25,,1323103657,7/14/2014 21:14:40,prodege,0.7639,28255346,GBR,L9,Sheffield,2.125.183.137,DISSECTION OF AORTA is location of AORTA,51,37,,55,56,is location of,0.960768922830523,905375-FS1-9,Cjest computerized tomography showed DISSECTION OF AORTA from ascending to descendig aorta and hemorrhage around ascending AORTA.,AORTA,DISSECTION OF AORTA,RO-has_finding_site
503007617,7/14/2014 21:24:28,,1323107650,7/14/2014 21:24:18,clixsense,0.5625,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,51,37,,55,56,is location of,0.960768922830523,905375-FS1-9,Cjest computerized tomography showed DISSECTION OF AORTA from ascending to descendig aorta and hemorrhage around ascending AORTA.,AORTA,DISSECTION OF AORTA,RO-has_finding_site
503007617,7/14/2014 21:36:19,,1323114176,7/14/2014 21:35:54,clixsense,0.5974,19803139,NLD,06,Veldhoven,212.61.84.196,AORTA is location of DISSECTION OF AORTA,51,37,,55,56,is location of,0.960768922830523,905375-FS1-9,Cjest computerized tomography showed DISSECTION OF AORTA from ascending to descendig aorta and hemorrhage around ascending AORTA.,AORTA,DISSECTION OF AORTA,RO-has_finding_site
503007617,7/14/2014 21:43:59,,1323119788,7/14/2014 21:43:11,neodev,0.6153,27597779,CAN,AB,Calgary,72.29.251.209,AORTA is location of DISSECTION OF AORTA,51,37,,55,56,is location of,0.960768922830523,905375-FS1-9,Cjest computerized tomography showed DISSECTION OF AORTA from ascending to descendig aorta and hemorrhage around ascending AORTA.,AORTA,DISSECTION OF AORTA,RO-has_finding_site
503007617,7/14/2014 22:28:11,,1323145288,7/14/2014 22:27:28,clixsense,0.5752,15189335,GBR,K3,Peterborough,81.156.166.189,AORTA is location of DISSECTION OF AORTA,51,37,,55,56,is location of,0.960768922830523,905375-FS1-9,Cjest computerized tomography showed DISSECTION OF AORTA from ascending to descendig aorta and hemorrhage around ascending AORTA.,AORTA,DISSECTION OF AORTA,RO-has_finding_site
503007617,7/14/2014 22:32:08,,1323146952,7/14/2014 22:32:03,clixsense,0.3016,25419319,GBR,H8,Liverpool,94.4.192.228,AORTA is location of DISSECTION OF AORTA,51,37,,55,56,is location of,0.960768922830523,905375-FS1-9,Cjest computerized tomography showed DISSECTION OF AORTA from ascending to descendig aorta and hemorrhage around ascending AORTA.,AORTA,DISSECTION OF AORTA,RO-has_finding_site
503007618,7/14/2014 21:45:21,,1323120885,7/14/2014 21:45:11,prodege,0.5819,2143114,CAN,BC,Vancouver,24.84.160.12,PHEOCHROMOCYTOMA treats ARTERIAL HYPERTENSION,27,66,,47,82,treats,0.960768922830523,902920-FS1-2,2]  Dimopoulos C. [Cure of ARTERIAL HYPERTENSION by excision of a PHEOCHROMOCYTOMA (2 cases.,ARTERIAL HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503007618,7/14/2014 21:46:57,,1323122213,7/14/2014 21:46:17,instagc,0.6292,21551272,GBR,E6,Chipping Campden,78.145.193.123,no_relation,27,66,,47,82,treats,0.960768922830523,902920-FS1-2,2]  Dimopoulos C. [Cure of ARTERIAL HYPERTENSION by excision of a PHEOCHROMOCYTOMA (2 cases.,ARTERIAL HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503007618,7/14/2014 21:49:06,,1323123424,7/14/2014 21:48:39,clixsense,0.5155,26889820,GBR,C3,Shelford,92.18.120.203,no_relation,27,66,,47,82,treats,0.960768922830523,902920-FS1-2,2]  Dimopoulos C. [Cure of ARTERIAL HYPERTENSION by excision of a PHEOCHROMOCYTOMA (2 cases.,ARTERIAL HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503007618,7/14/2014 22:07:17,,1323132246,7/14/2014 22:06:56,instagc,0.5915,18960682,GBR,"","",86.29.147.112,PHEOCHROMOCYTOMA treats ARTERIAL HYPERTENSION,27,66,,47,82,treats,0.960768922830523,902920-FS1-2,2]  Dimopoulos C. [Cure of ARTERIAL HYPERTENSION by excision of a PHEOCHROMOCYTOMA (2 cases.,ARTERIAL HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503007618,7/14/2014 22:30:05,,1323146018,7/14/2014 22:29:28,instagc,0.5867,23149109,USA,NC,Durham,75.189.206.205,PHEOCHROMOCYTOMA treats ARTERIAL HYPERTENSION,27,66,,47,82,treats,0.960768922830523,902920-FS1-2,2]  Dimopoulos C. [Cure of ARTERIAL HYPERTENSION by excision of a PHEOCHROMOCYTOMA (2 cases.,ARTERIAL HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503007618,7/14/2014 22:32:32,,1323147103,7/14/2014 22:32:27,clixsense,0.3016,25419319,GBR,H8,Liverpool,94.4.192.228,ARTERIAL HYPERTENSION treats PHEOCHROMOCYTOMA,27,66,,47,82,treats,0.960768922830523,902920-FS1-2,2]  Dimopoulos C. [Cure of ARTERIAL HYPERTENSION by excision of a PHEOCHROMOCYTOMA (2 cases.,ARTERIAL HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503007618,7/14/2014 22:51:45,,1323154699,7/14/2014 22:51:27,instagc,0.6238,19686223,CAN,BC,Surrey,184.65.16.6,PHEOCHROMOCYTOMA treats ARTERIAL HYPERTENSION,27,66,,47,82,treats,0.960768922830523,902920-FS1-2,2]  Dimopoulos C. [Cure of ARTERIAL HYPERTENSION by excision of a PHEOCHROMOCYTOMA (2 cases.,ARTERIAL HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503007619,7/14/2014 20:45:51,,1323088608,7/14/2014 20:45:48,instagc,0.6111,25990856,USA,NV,Las Vegas,68.108.98.78,OSTEOARTHRITIS THAT INVOLVES JOINTS is location of OSTEOARTHRITIS,234,234,,268,248,is location of,0.480384461415261,902437-FS1-9,C]  Specific recommendation: ? Consider referral to a rheumatologist for diagnostic consultation for CPPD disease/pseudogout in patients with: ? Inflammatory arthritis ? Osteoarthritis that appears to have an inflammatory component ? OSTEOARTHRITIS THAT INVOLVES JOINTS that are not usually affected by OSTEOARTHRITIS ? Consider referral to other specialists for patients with signs and symptoms of other underlying diseases such as: ? Hemochromatosis ? Hyperparathyroidism ? Acromegaly ? See module  Osteoarthritis.,OSTEOARTHRITIS THAT INVOLVES JOINTS,OSTEOARTHRITIS,RO-disease_has_primary_anatomic_site
503007619,7/14/2014 21:13:08,,1323102568,7/14/2014 21:12:39,elite,0.8694,28276268,USA,MI,Taylor,67.149.247.166,OSTEOARTHRITIS THAT INVOLVES JOINTS is location of OSTEOARTHRITIS,234,234,,268,248,is location of,0.480384461415261,902437-FS1-9,C]  Specific recommendation: ? Consider referral to a rheumatologist for diagnostic consultation for CPPD disease/pseudogout in patients with: ? Inflammatory arthritis ? Osteoarthritis that appears to have an inflammatory component ? OSTEOARTHRITIS THAT INVOLVES JOINTS that are not usually affected by OSTEOARTHRITIS ? Consider referral to other specialists for patients with signs and symptoms of other underlying diseases such as: ? Hemochromatosis ? Hyperparathyroidism ? Acromegaly ? See module  Osteoarthritis.,OSTEOARTHRITIS THAT INVOLVES JOINTS,OSTEOARTHRITIS,RO-disease_has_primary_anatomic_site
503007619,7/14/2014 21:31:15,,1323111418,7/14/2014 21:30:45,instagc,0.6498,19602039,USA,WA,Bellevue,50.135.214.140,no_relation,234,234,,268,248,is location of,0.480384461415261,902437-FS1-9,C]  Specific recommendation: ? Consider referral to a rheumatologist for diagnostic consultation for CPPD disease/pseudogout in patients with: ? Inflammatory arthritis ? Osteoarthritis that appears to have an inflammatory component ? OSTEOARTHRITIS THAT INVOLVES JOINTS that are not usually affected by OSTEOARTHRITIS ? Consider referral to other specialists for patients with signs and symptoms of other underlying diseases such as: ? Hemochromatosis ? Hyperparathyroidism ? Acromegaly ? See module  Osteoarthritis.,OSTEOARTHRITIS THAT INVOLVES JOINTS,OSTEOARTHRITIS,RO-disease_has_primary_anatomic_site
503007619,7/14/2014 21:32:05,,1323111852,7/14/2014 21:31:40,tremorgames,0.5903,28013393,USA,CA,Rancho Cordova,71.197.67.37,OSTEOARTHRITIS THAT INVOLVES JOINTS is location of OSTEOARTHRITIS,234,234,,268,248,is location of,0.480384461415261,902437-FS1-9,C]  Specific recommendation: ? Consider referral to a rheumatologist for diagnostic consultation for CPPD disease/pseudogout in patients with: ? Inflammatory arthritis ? Osteoarthritis that appears to have an inflammatory component ? OSTEOARTHRITIS THAT INVOLVES JOINTS that are not usually affected by OSTEOARTHRITIS ? Consider referral to other specialists for patients with signs and symptoms of other underlying diseases such as: ? Hemochromatosis ? Hyperparathyroidism ? Acromegaly ? See module  Osteoarthritis.,OSTEOARTHRITIS THAT INVOLVES JOINTS,OSTEOARTHRITIS,RO-disease_has_primary_anatomic_site
503007619,7/14/2014 21:44:24,,1323120073,7/14/2014 21:44:12,prodege,0.5819,2143114,CAN,BC,Vancouver,24.84.160.12,OSTEOARTHRITIS is location of OSTEOARTHRITIS THAT INVOLVES JOINTS,234,234,,268,248,is location of,0.480384461415261,902437-FS1-9,C]  Specific recommendation: ? Consider referral to a rheumatologist for diagnostic consultation for CPPD disease/pseudogout in patients with: ? Inflammatory arthritis ? Osteoarthritis that appears to have an inflammatory component ? OSTEOARTHRITIS THAT INVOLVES JOINTS that are not usually affected by OSTEOARTHRITIS ? Consider referral to other specialists for patients with signs and symptoms of other underlying diseases such as: ? Hemochromatosis ? Hyperparathyroidism ? Acromegaly ? See module  Osteoarthritis.,OSTEOARTHRITIS THAT INVOLVES JOINTS,OSTEOARTHRITIS,RO-disease_has_primary_anatomic_site
503007619,7/14/2014 21:47:46,,1323122694,7/14/2014 21:46:59,instagc,0.6292,21551272,GBR,E6,Chipping Campden,78.145.193.123,no_relation,234,234,,268,248,is location of,0.480384461415261,902437-FS1-9,C]  Specific recommendation: ? Consider referral to a rheumatologist for diagnostic consultation for CPPD disease/pseudogout in patients with: ? Inflammatory arthritis ? Osteoarthritis that appears to have an inflammatory component ? OSTEOARTHRITIS THAT INVOLVES JOINTS that are not usually affected by OSTEOARTHRITIS ? Consider referral to other specialists for patients with signs and symptoms of other underlying diseases such as: ? Hemochromatosis ? Hyperparathyroidism ? Acromegaly ? See module  Osteoarthritis.,OSTEOARTHRITIS THAT INVOLVES JOINTS,OSTEOARTHRITIS,RO-disease_has_primary_anatomic_site
503007619,7/14/2014 22:07:17,,1323132245,7/14/2014 22:06:56,instagc,0.5915,18960682,GBR,"","",86.29.147.112,no_relation,234,234,,268,248,is location of,0.480384461415261,902437-FS1-9,C]  Specific recommendation: ? Consider referral to a rheumatologist for diagnostic consultation for CPPD disease/pseudogout in patients with: ? Inflammatory arthritis ? Osteoarthritis that appears to have an inflammatory component ? OSTEOARTHRITIS THAT INVOLVES JOINTS that are not usually affected by OSTEOARTHRITIS ? Consider referral to other specialists for patients with signs and symptoms of other underlying diseases such as: ? Hemochromatosis ? Hyperparathyroidism ? Acromegaly ? See module  Osteoarthritis.,OSTEOARTHRITIS THAT INVOLVES JOINTS,OSTEOARTHRITIS,RO-disease_has_primary_anatomic_site
503007620,7/14/2014 20:34:42,,1323082997,7/14/2014 20:34:17,clixsense,0.9583,27871219,NLD,07,Amsterdam,87.210.207.223,INTERFERON treats MULTIPLE MYELOMA,76,35,,91,45,treats,0.625543242171224,907872-FS1-2,"Einhorn S, Ahre A, Blomgren H et alINTERFERON and naturl killer activity in MULTIPLE MYELOMA",MULTIPLE MYELOMA,INTERFERON,RO-may_treat
503007620,7/14/2014 20:46:04,,1323088758,7/14/2014 20:46:01,instagc,0.6111,25990856,USA,NV,Las Vegas,68.108.98.78,no_relation,76,35,,91,45,treats,0.625543242171224,907872-FS1-2,"Einhorn S, Ahre A, Blomgren H et alINTERFERON and naturl killer activity in MULTIPLE MYELOMA",MULTIPLE MYELOMA,INTERFERON,RO-may_treat
503007620,7/14/2014 21:24:02,,1323107440,7/14/2014 21:22:59,prodege,0.7639,28255346,GBR,L9,Sheffield,2.125.183.137,INTERFERON treats MULTIPLE MYELOMA,76,35,,91,45,treats,0.625543242171224,907872-FS1-2,"Einhorn S, Ahre A, Blomgren H et alINTERFERON and naturl killer activity in MULTIPLE MYELOMA",MULTIPLE MYELOMA,INTERFERON,RO-may_treat
503007620,7/14/2014 21:26:26,,1323108718,7/14/2014 21:26:17,prodege,0.7306,23541832,USA,AZ,Tempe,149.169.129.225,INTERFERON treats MULTIPLE MYELOMA,76,35,,91,45,treats,0.625543242171224,907872-FS1-2,"Einhorn S, Ahre A, Blomgren H et alINTERFERON and naturl killer activity in MULTIPLE MYELOMA",MULTIPLE MYELOMA,INTERFERON,RO-may_treat
503007620,7/14/2014 21:30:43,,1323111117,7/14/2014 21:30:07,instagc,0.6498,19602039,USA,WA,Bellevue,50.135.214.140,INTERFERON treats MULTIPLE MYELOMA,76,35,,91,45,treats,0.625543242171224,907872-FS1-2,"Einhorn S, Ahre A, Blomgren H et alINTERFERON and naturl killer activity in MULTIPLE MYELOMA",MULTIPLE MYELOMA,INTERFERON,RO-may_treat
503007620,7/14/2014 21:31:38,,1323111637,7/14/2014 21:31:09,tremorgames,0.5903,28013393,USA,CA,Rancho Cordova,71.197.67.37,no_relation,76,35,,91,45,treats,0.625543242171224,907872-FS1-2,"Einhorn S, Ahre A, Blomgren H et alINTERFERON and naturl killer activity in MULTIPLE MYELOMA",MULTIPLE MYELOMA,INTERFERON,RO-may_treat
503007620,7/14/2014 21:37:29,,1323114863,7/14/2014 21:37:06,clixsense,0.5974,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,76,35,,91,45,treats,0.625543242171224,907872-FS1-2,"Einhorn S, Ahre A, Blomgren H et alINTERFERON and naturl killer activity in MULTIPLE MYELOMA",MULTIPLE MYELOMA,INTERFERON,RO-may_treat
503007621,7/14/2014 20:34:10,,1323082732,7/14/2014 20:33:45,neodev,0.9583,21515166,NLD,11,Nootdorp,83.86.58.179,INSULIN treats HYPERGLYCEMIA,71,0,,83,7,treats,0.992277876713668,907972-FS1-2,INSULIN and fluid and electrolyte therapy are initiated to control the HYPERGLYCEMIA and prevent shock and further complications.,HYPERGLYCEMIA,INSULIN,RO-may_treat
503007621,7/14/2014 20:42:56,,1323087138,7/14/2014 20:42:41,elite,0.875,28503042,USA,NJ,Woodbridge,54.191.150.115,INSULIN treats HYPERGLYCEMIA,71,0,,83,7,treats,0.992277876713668,907972-FS1-2,INSULIN and fluid and electrolyte therapy are initiated to control the HYPERGLYCEMIA and prevent shock and further complications.,HYPERGLYCEMIA,INSULIN,RO-may_treat
503007621,7/14/2014 21:12:35,,1323102356,7/14/2014 21:12:15,elite,0.8694,28276268,USA,MI,Taylor,67.149.247.166,INSULIN treats HYPERGLYCEMIA,71,0,,83,7,treats,0.992277876713668,907972-FS1-2,INSULIN and fluid and electrolyte therapy are initiated to control the HYPERGLYCEMIA and prevent shock and further complications.,HYPERGLYCEMIA,INSULIN,RO-may_treat
503007621,7/14/2014 21:32:21,,1323111975,7/14/2014 21:32:07,tremorgames,0.5903,28013393,USA,CA,Rancho Cordova,71.197.67.37,INSULIN treats HYPERGLYCEMIA,71,0,,83,7,treats,0.992277876713668,907972-FS1-2,INSULIN and fluid and electrolyte therapy are initiated to control the HYPERGLYCEMIA and prevent shock and further complications.,HYPERGLYCEMIA,INSULIN,RO-may_treat
503007621,7/14/2014 21:35:54,,1323113924,7/14/2014 21:35:30,clixsense,0.5974,19803139,NLD,06,Veldhoven,212.61.84.196,INSULIN treats HYPERGLYCEMIA,71,0,,83,7,treats,0.992277876713668,907972-FS1-2,INSULIN and fluid and electrolyte therapy are initiated to control the HYPERGLYCEMIA and prevent shock and further complications.,HYPERGLYCEMIA,INSULIN,RO-may_treat
503007621,7/14/2014 21:40:17,,1323116795,7/14/2014 21:39:59,instagc,0.7958,28301350,GBR,K4,Plymouth,92.28.215.248,INSULIN treats HYPERGLYCEMIA,71,0,,83,7,treats,0.992277876713668,907972-FS1-2,INSULIN and fluid and electrolyte therapy are initiated to control the HYPERGLYCEMIA and prevent shock and further complications.,HYPERGLYCEMIA,INSULIN,RO-may_treat
503007621,7/14/2014 21:44:31,,1323120251,7/14/2014 21:44:03,instagc,0.6292,21551272,GBR,E6,Chipping Campden,78.145.193.123,INSULIN treats HYPERGLYCEMIA,71,0,,83,7,treats,0.992277876713668,907972-FS1-2,INSULIN and fluid and electrolyte therapy are initiated to control the HYPERGLYCEMIA and prevent shock and further complications.,HYPERGLYCEMIA,INSULIN,RO-may_treat
503007622,7/14/2014 20:33:22,,1323082371,7/14/2014 20:33:06,neodev,0.9583,21515166,NLD,11,Nootdorp,83.86.58.179,LITHIUM treats BIPOLAR DISORDER,337,251,,352,258,treats,0.984731927834662,907591-FS1-2,"30  Efficacy in the acute treatment of mood episodes has yet to be fully established,  31   but is considered a first line agent by the APA for the management of acute depressive episodes in patients with bipolar disorder   +    and an alternative to LITHIUM valproic acid, or divalproex in the management of patients with rapid cycling BIPOLAR DISORDER   +   , particularly in those with the bipolar 2 form of rapid cycling.",BIPOLAR DISORDER,LITHIUM,RO-may_treat
503007622,7/14/2014 20:41:48,,1323086614,7/14/2014 20:41:27,elite,0.875,28503042,USA,NJ,Woodbridge,54.191.150.115,LITHIUM treats BIPOLAR DISORDER,337,251,,352,258,treats,0.984731927834662,907591-FS1-2,"30  Efficacy in the acute treatment of mood episodes has yet to be fully established,  31   but is considered a first line agent by the APA for the management of acute depressive episodes in patients with bipolar disorder   +    and an alternative to LITHIUM valproic acid, or divalproex in the management of patients with rapid cycling BIPOLAR DISORDER   +   , particularly in those with the bipolar 2 form of rapid cycling.",BIPOLAR DISORDER,LITHIUM,RO-may_treat
503007622,7/14/2014 20:46:04,,1323088742,7/14/2014 20:46:01,instagc,0.6111,25990856,USA,NV,Las Vegas,68.108.98.78,BIPOLAR DISORDER treats LITHIUM,337,251,,352,258,treats,0.984731927834662,907591-FS1-2,"30  Efficacy in the acute treatment of mood episodes has yet to be fully established,  31   but is considered a first line agent by the APA for the management of acute depressive episodes in patients with bipolar disorder   +    and an alternative to LITHIUM valproic acid, or divalproex in the management of patients with rapid cycling BIPOLAR DISORDER   +   , particularly in those with the bipolar 2 form of rapid cycling.",BIPOLAR DISORDER,LITHIUM,RO-may_treat
503007622,7/14/2014 21:24:02,,1323107439,7/14/2014 21:22:59,prodege,0.7639,28255346,GBR,L9,Sheffield,2.125.183.137,LITHIUM treats BIPOLAR DISORDER,337,251,,352,258,treats,0.984731927834662,907591-FS1-2,"30  Efficacy in the acute treatment of mood episodes has yet to be fully established,  31   but is considered a first line agent by the APA for the management of acute depressive episodes in patients with bipolar disorder   +    and an alternative to LITHIUM valproic acid, or divalproex in the management of patients with rapid cycling BIPOLAR DISORDER   +   , particularly in those with the bipolar 2 form of rapid cycling.",BIPOLAR DISORDER,LITHIUM,RO-may_treat
503007622,7/14/2014 21:37:34,,1323114903,7/14/2014 21:37:28,clixsense,0.4925,19162475,GBR,M3,Frome,82.33.126.30,LITHIUM treats BIPOLAR DISORDER,337,251,,352,258,treats,0.984731927834662,907591-FS1-2,"30  Efficacy in the acute treatment of mood episodes has yet to be fully established,  31   but is considered a first line agent by the APA for the management of acute depressive episodes in patients with bipolar disorder   +    and an alternative to LITHIUM valproic acid, or divalproex in the management of patients with rapid cycling BIPOLAR DISORDER   +   , particularly in those with the bipolar 2 form of rapid cycling.",BIPOLAR DISORDER,LITHIUM,RO-may_treat
503007622,7/14/2014 21:38:56,,1323115792,7/14/2014 21:38:33,instagc,0.7958,28301350,GBR,K4,Plymouth,92.28.215.248,LITHIUM treats BIPOLAR DISORDER,337,251,,352,258,treats,0.984731927834662,907591-FS1-2,"30  Efficacy in the acute treatment of mood episodes has yet to be fully established,  31   but is considered a first line agent by the APA for the management of acute depressive episodes in patients with bipolar disorder   +    and an alternative to LITHIUM valproic acid, or divalproex in the management of patients with rapid cycling BIPOLAR DISORDER   +   , particularly in those with the bipolar 2 form of rapid cycling.",BIPOLAR DISORDER,LITHIUM,RO-may_treat
503007622,7/14/2014 22:30:05,,1323146019,7/14/2014 22:29:28,instagc,0.5867,23149109,USA,NC,Durham,75.189.206.205,LITHIUM treats BIPOLAR DISORDER,337,251,,352,258,treats,0.984731927834662,907591-FS1-2,"30  Efficacy in the acute treatment of mood episodes has yet to be fully established,  31   but is considered a first line agent by the APA for the management of acute depressive episodes in patients with bipolar disorder   +    and an alternative to LITHIUM valproic acid, or divalproex in the management of patients with rapid cycling BIPOLAR DISORDER   +   , particularly in those with the bipolar 2 form of rapid cycling.",BIPOLAR DISORDER,LITHIUM,RO-may_treat
503007623,7/14/2014 20:43:45,,1323087605,7/14/2014 20:43:24,elite,0.875,28503042,USA,NJ,Woodbridge,54.191.150.115,no_relation,64,28,,87,48,causes,0.38490017945975,901763-FS1-4,Forty one (30.1%) women had MILD DYSPLASIA/CIN 1 21 (15.4%) had MODERATE DYSPLASIA/CIN 2 and 17 (12.5%) had severe dysplasia/CIN 3.,MODERATE DYSPLASIA/CIN 2,MILD DYSPLASIA/CIN 1,RO-disease_has_finding
503007623,7/14/2014 20:49:22,,1323090397,7/14/2014 20:49:01,zoombucks,0.875,28232452,USA,NC,Cary,174.97.217.113,no_relation,64,28,,87,48,causes,0.38490017945975,901763-FS1-4,Forty one (30.1%) women had MILD DYSPLASIA/CIN 1 21 (15.4%) had MODERATE DYSPLASIA/CIN 2 and 17 (12.5%) had severe dysplasia/CIN 3.,MODERATE DYSPLASIA/CIN 2,MILD DYSPLASIA/CIN 1,RO-disease_has_finding
503007623,7/14/2014 21:26:41,,1323108867,7/14/2014 21:26:27,prodege,0.7306,23541832,USA,AZ,Tempe,149.169.129.225,no_relation,64,28,,87,48,causes,0.38490017945975,901763-FS1-4,Forty one (30.1%) women had MILD DYSPLASIA/CIN 1 21 (15.4%) had MODERATE DYSPLASIA/CIN 2 and 17 (12.5%) had severe dysplasia/CIN 3.,MODERATE DYSPLASIA/CIN 2,MILD DYSPLASIA/CIN 1,RO-disease_has_finding
503007623,7/14/2014 21:33:03,,1323112399,7/14/2014 21:32:40,instagc,0.6498,19602039,USA,WA,Bellevue,50.135.214.140,no_relation,64,28,,87,48,causes,0.38490017945975,901763-FS1-4,Forty one (30.1%) women had MILD DYSPLASIA/CIN 1 21 (15.4%) had MODERATE DYSPLASIA/CIN 2 and 17 (12.5%) had severe dysplasia/CIN 3.,MODERATE DYSPLASIA/CIN 2,MILD DYSPLASIA/CIN 1,RO-disease_has_finding
503007623,7/14/2014 21:33:15,,1323112467,7/14/2014 21:33:06,tremorgames,0.5903,28013393,USA,CA,Rancho Cordova,71.197.67.37,MILD DYSPLASIA/CIN 1 causes MODERATE DYSPLASIA/CIN 2,64,28,,87,48,causes,0.38490017945975,901763-FS1-4,Forty one (30.1%) women had MILD DYSPLASIA/CIN 1 21 (15.4%) had MODERATE DYSPLASIA/CIN 2 and 17 (12.5%) had severe dysplasia/CIN 3.,MODERATE DYSPLASIA/CIN 2,MILD DYSPLASIA/CIN 1,RO-disease_has_finding
503007623,7/14/2014 21:39:58,,1323116460,7/14/2014 21:39:34,instagc,0.7958,28301350,GBR,K4,Plymouth,92.28.215.248,no_relation,64,28,,87,48,causes,0.38490017945975,901763-FS1-4,Forty one (30.1%) women had MILD DYSPLASIA/CIN 1 21 (15.4%) had MODERATE DYSPLASIA/CIN 2 and 17 (12.5%) had severe dysplasia/CIN 3.,MODERATE DYSPLASIA/CIN 2,MILD DYSPLASIA/CIN 1,RO-disease_has_finding
503007623,7/14/2014 21:45:30,,1323121029,7/14/2014 21:44:24,clixsense,0.6786,13328793,GBR,G5,Maidstone,2.103.33.237,no_relation,64,28,,87,48,causes,0.38490017945975,901763-FS1-4,Forty one (30.1%) women had MILD DYSPLASIA/CIN 1 21 (15.4%) had MODERATE DYSPLASIA/CIN 2 and 17 (12.5%) had severe dysplasia/CIN 3.,MODERATE DYSPLASIA/CIN 2,MILD DYSPLASIA/CIN 1,RO-disease_has_finding
503007624,7/14/2014 20:41:25,,1323086461,7/14/2014 20:41:04,elite,0.875,28503042,USA,NJ,Woodbridge,54.191.150.115,no_relation,126,160,,146,177,causes,0.547722557505166,901610-FS1-4,"Fifty non selected melanomas comprising ten superficial spreading melanomas (five exhibiting a radial growth phase and five a VERTICAL GROWTH PHASE ten primary NODULAR MELANOMAS 30 melanoma metastases, and 16 naevi were investigated by direct sequencing analysis of the AP 2alpha and c kit genes and by immunohistochemistry for the respective proteins.",VERTICAL GROWTH PHASE,NODULAR MELANOMAS,RO-disease_has_finding
503007624,7/14/2014 21:17:56,,1323104729,7/14/2014 21:17:03,prodege,0.7639,28255346,GBR,L9,Sheffield,2.125.183.137,no_relation,126,160,,146,177,causes,0.547722557505166,901610-FS1-4,"Fifty non selected melanomas comprising ten superficial spreading melanomas (five exhibiting a radial growth phase and five a VERTICAL GROWTH PHASE ten primary NODULAR MELANOMAS 30 melanoma metastases, and 16 naevi were investigated by direct sequencing analysis of the AP 2alpha and c kit genes and by immunohistochemistry for the respective proteins.",VERTICAL GROWTH PHASE,NODULAR MELANOMAS,RO-disease_has_finding
503007624,7/14/2014 21:24:16,,1323107561,7/14/2014 21:24:03,clixsense,0.5625,16827630,GBR,A7,Birmingham,86.146.169.103,NODULAR MELANOMAS causes VERTICAL GROWTH PHASE,126,160,,146,177,causes,0.547722557505166,901610-FS1-4,"Fifty non selected melanomas comprising ten superficial spreading melanomas (five exhibiting a radial growth phase and five a VERTICAL GROWTH PHASE ten primary NODULAR MELANOMAS 30 melanoma metastases, and 16 naevi were investigated by direct sequencing analysis of the AP 2alpha and c kit genes and by immunohistochemistry for the respective proteins.",VERTICAL GROWTH PHASE,NODULAR MELANOMAS,RO-disease_has_finding
503007624,7/14/2014 21:49:06,,1323123423,7/14/2014 21:48:39,clixsense,0.5155,26889820,GBR,C3,Shelford,92.18.120.203,no_relation,126,160,,146,177,causes,0.547722557505166,901610-FS1-4,"Fifty non selected melanomas comprising ten superficial spreading melanomas (five exhibiting a radial growth phase and five a VERTICAL GROWTH PHASE ten primary NODULAR MELANOMAS 30 melanoma metastases, and 16 naevi were investigated by direct sequencing analysis of the AP 2alpha and c kit genes and by immunohistochemistry for the respective proteins.",VERTICAL GROWTH PHASE,NODULAR MELANOMAS,RO-disease_has_finding
503007624,7/14/2014 22:30:44,,1323146299,7/14/2014 22:29:58,clixsense,0.5752,15189335,GBR,K3,Peterborough,81.156.166.189,VERTICAL GROWTH PHASE causes NODULAR MELANOMAS,126,160,,146,177,causes,0.547722557505166,901610-FS1-4,"Fifty non selected melanomas comprising ten superficial spreading melanomas (five exhibiting a radial growth phase and five a VERTICAL GROWTH PHASE ten primary NODULAR MELANOMAS 30 melanoma metastases, and 16 naevi were investigated by direct sequencing analysis of the AP 2alpha and c kit genes and by immunohistochemistry for the respective proteins.",VERTICAL GROWTH PHASE,NODULAR MELANOMAS,RO-disease_has_finding
503007624,7/14/2014 22:31:39,,1323146686,7/14/2014 22:31:14,instagc,0.5867,23149109,USA,NC,Durham,75.189.206.205,NODULAR MELANOMAS causes VERTICAL GROWTH PHASE,126,160,,146,177,causes,0.547722557505166,901610-FS1-4,"Fifty non selected melanomas comprising ten superficial spreading melanomas (five exhibiting a radial growth phase and five a VERTICAL GROWTH PHASE ten primary NODULAR MELANOMAS 30 melanoma metastases, and 16 naevi were investigated by direct sequencing analysis of the AP 2alpha and c kit genes and by immunohistochemistry for the respective proteins.",VERTICAL GROWTH PHASE,NODULAR MELANOMAS,RO-disease_has_finding
503007624,7/14/2014 22:50:50,,1323154241,7/14/2014 22:50:08,instagc,0.6238,19686223,CAN,BC,Surrey,184.65.16.6,no_relation,126,160,,146,177,causes,0.547722557505166,901610-FS1-4,"Fifty non selected melanomas comprising ten superficial spreading melanomas (five exhibiting a radial growth phase and five a VERTICAL GROWTH PHASE ten primary NODULAR MELANOMAS 30 melanoma metastases, and 16 naevi were investigated by direct sequencing analysis of the AP 2alpha and c kit genes and by immunohistochemistry for the respective proteins.",VERTICAL GROWTH PHASE,NODULAR MELANOMAS,RO-disease_has_finding
503007625,7/14/2014 20:33:22,,1323082370,7/14/2014 20:33:06,neodev,0.9583,21515166,NLD,11,Nootdorp,83.86.58.179,PATHOLOGICAL FRACTURES causes BONE METASTASES,35,0,,56,15,causes,1,902703-FS1-4,"BONE METASTASES cause severe pain, PATHOLOGICAL FRACTURES and hypercalcaemia and thus are a significant clinical problem.",PATHOLOGICAL FRACTURES,BONE METASTASES,RO-disease_may_have_finding
503007625,7/14/2014 20:33:55,,1323082642,7/14/2014 20:33:26,clixsense,0.9583,27871219,NLD,07,Amsterdam,87.210.207.223,BONE METASTASES causes PATHOLOGICAL FRACTURES,35,0,,56,15,causes,1,902703-FS1-4,"BONE METASTASES cause severe pain, PATHOLOGICAL FRACTURES and hypercalcaemia and thus are a significant clinical problem.",PATHOLOGICAL FRACTURES,BONE METASTASES,RO-disease_may_have_finding
503007625,7/14/2014 20:45:46,,1323088551,7/14/2014 20:45:43,instagc,0.6111,25990856,USA,NV,Las Vegas,68.108.98.78,no_relation,35,0,,56,15,causes,1,902703-FS1-4,"BONE METASTASES cause severe pain, PATHOLOGICAL FRACTURES and hypercalcaemia and thus are a significant clinical problem.",PATHOLOGICAL FRACTURES,BONE METASTASES,RO-disease_may_have_finding
503007625,7/14/2014 20:48:41,,1323090032,7/14/2014 20:48:21,zoombucks,0.875,28232452,USA,NC,Cary,174.97.217.113,BONE METASTASES causes PATHOLOGICAL FRACTURES,35,0,,56,15,causes,1,902703-FS1-4,"BONE METASTASES cause severe pain, PATHOLOGICAL FRACTURES and hypercalcaemia and thus are a significant clinical problem.",PATHOLOGICAL FRACTURES,BONE METASTASES,RO-disease_may_have_finding
503007625,7/14/2014 21:11:23,,1323101802,7/14/2014 21:10:37,elite,0.8694,28276268,USA,MI,Taylor,67.149.247.166,BONE METASTASES causes PATHOLOGICAL FRACTURES,35,0,,56,15,causes,1,902703-FS1-4,"BONE METASTASES cause severe pain, PATHOLOGICAL FRACTURES and hypercalcaemia and thus are a significant clinical problem.",PATHOLOGICAL FRACTURES,BONE METASTASES,RO-disease_may_have_finding
503007625,7/14/2014 21:26:26,,1323108719,7/14/2014 21:26:17,prodege,0.7306,23541832,USA,AZ,Tempe,149.169.129.225,BONE METASTASES causes PATHOLOGICAL FRACTURES,35,0,,56,15,causes,1,902703-FS1-4,"BONE METASTASES cause severe pain, PATHOLOGICAL FRACTURES and hypercalcaemia and thus are a significant clinical problem.",PATHOLOGICAL FRACTURES,BONE METASTASES,RO-disease_may_have_finding
503007625,7/14/2014 21:33:03,,1323112387,7/14/2014 21:32:40,instagc,0.6498,19602039,USA,WA,Bellevue,50.135.214.140,BONE METASTASES causes PATHOLOGICAL FRACTURES,35,0,,56,15,causes,1,902703-FS1-4,"BONE METASTASES cause severe pain, PATHOLOGICAL FRACTURES and hypercalcaemia and thus are a significant clinical problem.",PATHOLOGICAL FRACTURES,BONE METASTASES,RO-disease_may_have_finding
503007626,7/14/2014 21:34:22,,1323113088,7/14/2014 21:33:23,neodev,0.7333,18755947,GBR,H2,Accrington,80.47.185.52,no_relation,246,205,,253,221,causes,0.493196961916072,904788-FS1-4,The principal underlying concepts are (a) children with medically refractory infantile spasms may have an area of cortical defect (called the zone of cortical abnormality) that causes the seizures and (b) INFANTILE SPASMS are usually generalized SEIZURES.,SEIZURES,INFANTILE SPASMS,RO-has_definitional_manifestation
503007626,7/14/2014 21:46:57,,1323122215,7/14/2014 21:46:17,instagc,0.6292,21551272,GBR,E6,Chipping Campden,78.145.193.123,INFANTILE SPASMS causes SEIZURES,246,205,,253,221,causes,0.493196961916072,904788-FS1-4,The principal underlying concepts are (a) children with medically refractory infantile spasms may have an area of cortical defect (called the zone of cortical abnormality) that causes the seizures and (b) INFANTILE SPASMS are usually generalized SEIZURES.,SEIZURES,INFANTILE SPASMS,RO-has_definitional_manifestation
503007626,7/14/2014 21:50:59,,1323124398,7/14/2014 21:50:12,clixsense,0.5155,26889820,GBR,C3,Shelford,92.18.120.203,INFANTILE SPASMS causes SEIZURES,246,205,,253,221,causes,0.493196961916072,904788-FS1-4,The principal underlying concepts are (a) children with medically refractory infantile spasms may have an area of cortical defect (called the zone of cortical abnormality) that causes the seizures and (b) INFANTILE SPASMS are usually generalized SEIZURES.,SEIZURES,INFANTILE SPASMS,RO-has_definitional_manifestation
503007626,7/14/2014 21:55:54,,1323126295,7/14/2014 21:54:59,neodev,0.1667,11087793,GBR,K6,Southsea,82.24.115.185,no_relation,246,205,,253,221,causes,0.493196961916072,904788-FS1-4,The principal underlying concepts are (a) children with medically refractory infantile spasms may have an area of cortical defect (called the zone of cortical abnormality) that causes the seizures and (b) INFANTILE SPASMS are usually generalized SEIZURES.,SEIZURES,INFANTILE SPASMS,RO-has_definitional_manifestation
503007626,7/14/2014 22:07:31,,1323132442,7/14/2014 22:07:17,instagc,0.5915,18960682,GBR,"","",86.29.147.112,SEIZURES causes INFANTILE SPASMS,246,205,,253,221,causes,0.493196961916072,904788-FS1-4,The principal underlying concepts are (a) children with medically refractory infantile spasms may have an area of cortical defect (called the zone of cortical abnormality) that causes the seizures and (b) INFANTILE SPASMS are usually generalized SEIZURES.,SEIZURES,INFANTILE SPASMS,RO-has_definitional_manifestation
503007626,7/14/2014 22:32:15,,1323146967,7/14/2014 22:32:10,clixsense,0.3016,25419319,GBR,H8,Liverpool,94.4.192.228,INFANTILE SPASMS causes SEIZURES,246,205,,253,221,causes,0.493196961916072,904788-FS1-4,The principal underlying concepts are (a) children with medically refractory infantile spasms may have an area of cortical defect (called the zone of cortical abnormality) that causes the seizures and (b) INFANTILE SPASMS are usually generalized SEIZURES.,SEIZURES,INFANTILE SPASMS,RO-has_definitional_manifestation
503007626,7/14/2014 22:50:50,,1323154265,7/14/2014 22:50:08,instagc,0.6238,19686223,CAN,BC,Surrey,184.65.16.6,no_relation,246,205,,253,221,causes,0.493196961916072,904788-FS1-4,The principal underlying concepts are (a) children with medically refractory infantile spasms may have an area of cortical defect (called the zone of cortical abnormality) that causes the seizures and (b) INFANTILE SPASMS are usually generalized SEIZURES.,SEIZURES,INFANTILE SPASMS,RO-has_definitional_manifestation
503007627,7/14/2014 20:33:05,,1323082231,7/14/2014 20:32:48,clixsense,0.9583,27871219,NLD,07,Amsterdam,87.210.207.223,INTERFERON causes MULTIPLE MYELOMA,76,35,,91,45,causes,0.41702882811415,907872-FS1-4,"Einhorn S, Ahre A, Blomgren H et alINTERFERON and naturl killer activity in MULTIPLE MYELOMA",MULTIPLE MYELOMA,INTERFERON,RO-may_treat
503007627,7/14/2014 21:23:27,,1323107191,7/14/2014 21:23:12,clixsense,0.5625,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,76,35,,91,45,causes,0.41702882811415,907872-FS1-4,"Einhorn S, Ahre A, Blomgren H et alINTERFERON and naturl killer activity in MULTIPLE MYELOMA",MULTIPLE MYELOMA,INTERFERON,RO-may_treat
503007627,7/14/2014 21:39:12,,1323115982,7/14/2014 21:38:57,instagc,0.7958,28301350,GBR,K4,Plymouth,92.28.215.248,no_relation,76,35,,91,45,causes,0.41702882811415,907872-FS1-4,"Einhorn S, Ahre A, Blomgren H et alINTERFERON and naturl killer activity in MULTIPLE MYELOMA",MULTIPLE MYELOMA,INTERFERON,RO-may_treat
503007627,7/14/2014 21:48:38,,1323123148,7/14/2014 21:48:15,clixsense,0.5155,26889820,GBR,C3,Shelford,92.18.120.203,no_relation,76,35,,91,45,causes,0.41702882811415,907872-FS1-4,"Einhorn S, Ahre A, Blomgren H et alINTERFERON and naturl killer activity in MULTIPLE MYELOMA",MULTIPLE MYELOMA,INTERFERON,RO-may_treat
503007627,7/14/2014 22:28:11,,1323145290,7/14/2014 22:27:28,clixsense,0.5752,15189335,GBR,K3,Peterborough,81.156.166.189,no_relation,76,35,,91,45,causes,0.41702882811415,907872-FS1-4,"Einhorn S, Ahre A, Blomgren H et alINTERFERON and naturl killer activity in MULTIPLE MYELOMA",MULTIPLE MYELOMA,INTERFERON,RO-may_treat
503007627,7/14/2014 22:30:29,,1323146168,7/14/2014 22:30:06,instagc,0.5867,23149109,USA,NC,Durham,75.189.206.205,INTERFERON causes MULTIPLE MYELOMA,76,35,,91,45,causes,0.41702882811415,907872-FS1-4,"Einhorn S, Ahre A, Blomgren H et alINTERFERON and naturl killer activity in MULTIPLE MYELOMA",MULTIPLE MYELOMA,INTERFERON,RO-may_treat
503007627,7/14/2014 22:32:02,,1323146860,7/14/2014 22:31:26,clixsense,0.3016,25419319,GBR,H8,Liverpool,94.4.192.228,INTERFERON causes MULTIPLE MYELOMA,76,35,,91,45,causes,0.41702882811415,907872-FS1-4,"Einhorn S, Ahre A, Blomgren H et alINTERFERON and naturl killer activity in MULTIPLE MYELOMA",MULTIPLE MYELOMA,INTERFERON,RO-may_treat
503007628,7/14/2014 20:46:00,,1323088698,7/14/2014 20:45:57,instagc,0.6111,25990856,USA,NV,Las Vegas,68.108.98.78,OSTEOARTHRITIS THAT INVOLVES JOINTS causes OSTEOARTHRITIS,234,234,,268,248,causes,0.800640769025436,902437-FS1-4,C]  Specific recommendation: ? Consider referral to a rheumatologist for diagnostic consultation for CPPD disease/pseudogout in patients with: ? Inflammatory arthritis ? Osteoarthritis that appears to have an inflammatory component ? OSTEOARTHRITIS THAT INVOLVES JOINTS that are not usually affected by OSTEOARTHRITIS ? Consider referral to other specialists for patients with signs and symptoms of other underlying diseases such as: ? Hemochromatosis ? Hyperparathyroidism ? Acromegaly ? See module  Osteoarthritis.,OSTEOARTHRITIS THAT INVOLVES JOINTS,OSTEOARTHRITIS,RO-disease_has_primary_anatomic_site
503007628,7/14/2014 21:16:27,,1323104144,7/14/2014 21:15:27,prodege,0.7639,28255346,GBR,L9,Sheffield,2.125.183.137,no_relation,234,234,,268,248,causes,0.800640769025436,902437-FS1-4,C]  Specific recommendation: ? Consider referral to a rheumatologist for diagnostic consultation for CPPD disease/pseudogout in patients with: ? Inflammatory arthritis ? Osteoarthritis that appears to have an inflammatory component ? OSTEOARTHRITIS THAT INVOLVES JOINTS that are not usually affected by OSTEOARTHRITIS ? Consider referral to other specialists for patients with signs and symptoms of other underlying diseases such as: ? Hemochromatosis ? Hyperparathyroidism ? Acromegaly ? See module  Osteoarthritis.,OSTEOARTHRITIS THAT INVOLVES JOINTS,OSTEOARTHRITIS,RO-disease_has_primary_anatomic_site
503007628,7/14/2014 21:27:11,,1323109127,7/14/2014 21:27:03,prodege,0.7306,23541832,USA,AZ,Tempe,149.169.129.225,no_relation,234,234,,268,248,causes,0.800640769025436,902437-FS1-4,C]  Specific recommendation: ? Consider referral to a rheumatologist for diagnostic consultation for CPPD disease/pseudogout in patients with: ? Inflammatory arthritis ? Osteoarthritis that appears to have an inflammatory component ? OSTEOARTHRITIS THAT INVOLVES JOINTS that are not usually affected by OSTEOARTHRITIS ? Consider referral to other specialists for patients with signs and symptoms of other underlying diseases such as: ? Hemochromatosis ? Hyperparathyroidism ? Acromegaly ? See module  Osteoarthritis.,OSTEOARTHRITIS THAT INVOLVES JOINTS,OSTEOARTHRITIS,RO-disease_has_primary_anatomic_site
503007628,7/14/2014 21:32:39,,1323112139,7/14/2014 21:31:51,instagc,0.6498,19602039,USA,WA,Bellevue,50.135.214.140,no_relation,234,234,,268,248,causes,0.800640769025436,902437-FS1-4,C]  Specific recommendation: ? Consider referral to a rheumatologist for diagnostic consultation for CPPD disease/pseudogout in patients with: ? Inflammatory arthritis ? Osteoarthritis that appears to have an inflammatory component ? OSTEOARTHRITIS THAT INVOLVES JOINTS that are not usually affected by OSTEOARTHRITIS ? Consider referral to other specialists for patients with signs and symptoms of other underlying diseases such as: ? Hemochromatosis ? Hyperparathyroidism ? Acromegaly ? See module  Osteoarthritis.,OSTEOARTHRITIS THAT INVOLVES JOINTS,OSTEOARTHRITIS,RO-disease_has_primary_anatomic_site
503007628,7/14/2014 21:33:22,,1323112519,7/14/2014 21:33:09,neodev,0.7333,18755947,GBR,H2,Accrington,80.47.185.52,no_relation,234,234,,268,248,causes,0.800640769025436,902437-FS1-4,C]  Specific recommendation: ? Consider referral to a rheumatologist for diagnostic consultation for CPPD disease/pseudogout in patients with: ? Inflammatory arthritis ? Osteoarthritis that appears to have an inflammatory component ? OSTEOARTHRITIS THAT INVOLVES JOINTS that are not usually affected by OSTEOARTHRITIS ? Consider referral to other specialists for patients with signs and symptoms of other underlying diseases such as: ? Hemochromatosis ? Hyperparathyroidism ? Acromegaly ? See module  Osteoarthritis.,OSTEOARTHRITIS THAT INVOLVES JOINTS,OSTEOARTHRITIS,RO-disease_has_primary_anatomic_site
503007628,7/14/2014 21:36:40,,1323114385,7/14/2014 21:36:19,clixsense,0.5974,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,234,234,,268,248,causes,0.800640769025436,902437-FS1-4,C]  Specific recommendation: ? Consider referral to a rheumatologist for diagnostic consultation for CPPD disease/pseudogout in patients with: ? Inflammatory arthritis ? Osteoarthritis that appears to have an inflammatory component ? OSTEOARTHRITIS THAT INVOLVES JOINTS that are not usually affected by OSTEOARTHRITIS ? Consider referral to other specialists for patients with signs and symptoms of other underlying diseases such as: ? Hemochromatosis ? Hyperparathyroidism ? Acromegaly ? See module  Osteoarthritis.,OSTEOARTHRITIS THAT INVOLVES JOINTS,OSTEOARTHRITIS,RO-disease_has_primary_anatomic_site
503007628,7/14/2014 21:48:38,,1323123144,7/14/2014 21:48:15,clixsense,0.5155,26889820,GBR,C3,Shelford,92.18.120.203,no_relation,234,234,,268,248,causes,0.800640769025436,902437-FS1-4,C]  Specific recommendation: ? Consider referral to a rheumatologist for diagnostic consultation for CPPD disease/pseudogout in patients with: ? Inflammatory arthritis ? Osteoarthritis that appears to have an inflammatory component ? OSTEOARTHRITIS THAT INVOLVES JOINTS that are not usually affected by OSTEOARTHRITIS ? Consider referral to other specialists for patients with signs and symptoms of other underlying diseases such as: ? Hemochromatosis ? Hyperparathyroidism ? Acromegaly ? See module  Osteoarthritis.,OSTEOARTHRITIS THAT INVOLVES JOINTS,OSTEOARTHRITIS,RO-disease_has_primary_anatomic_site
503007629,7/14/2014 20:48:20,,1323089846,7/14/2014 20:47:54,zoombucks,0.875,28232452,USA,NC,Cary,174.97.217.113,MINOCYCLINE IS A TETRACYCLINE DERIVATIVE treats ACNE VULGARIS,73,0,,85,40,treats,0.98058067569092,907990-FS1-2,MINOCYCLINE IS A TETRACYCLINE DERIVATIVE mainly used in the treatment of ACNE VULGARIS in young persons.,ACNE VULGARIS,MINOCYCLINE IS A TETRACYCLINE DERIVATIVE,RO-may_treat
503007629,7/14/2014 20:52:13,,1323091927,7/14/2014 20:51:31,clixsense,0.5,6574199,USA,TX,San Antonio,207.230.144.242,MINOCYCLINE IS A TETRACYCLINE DERIVATIVE treats ACNE VULGARIS,73,0,,85,40,treats,0.98058067569092,907990-FS1-2,MINOCYCLINE IS A TETRACYCLINE DERIVATIVE mainly used in the treatment of ACNE VULGARIS in young persons.,ACNE VULGARIS,MINOCYCLINE IS A TETRACYCLINE DERIVATIVE,RO-may_treat
503007629,7/14/2014 21:10:37,,1323101460,7/14/2014 21:10:10,prodege,0.7306,23541832,USA,AZ,Tempe,149.169.129.225,MINOCYCLINE IS A TETRACYCLINE DERIVATIVE treats ACNE VULGARIS,73,0,,85,40,treats,0.98058067569092,907990-FS1-2,MINOCYCLINE IS A TETRACYCLINE DERIVATIVE mainly used in the treatment of ACNE VULGARIS in young persons.,ACNE VULGARIS,MINOCYCLINE IS A TETRACYCLINE DERIVATIVE,RO-may_treat
503007629,7/14/2014 21:32:21,,1323111974,7/14/2014 21:32:07,tremorgames,0.5903,28013393,USA,CA,Rancho Cordova,71.197.67.37,MINOCYCLINE IS A TETRACYCLINE DERIVATIVE treats ACNE VULGARIS,73,0,,85,40,treats,0.98058067569092,907990-FS1-2,MINOCYCLINE IS A TETRACYCLINE DERIVATIVE mainly used in the treatment of ACNE VULGARIS in young persons.,ACNE VULGARIS,MINOCYCLINE IS A TETRACYCLINE DERIVATIVE,RO-may_treat
503007629,7/14/2014 21:43:11,,1323119141,7/14/2014 21:42:45,neodev,0.6153,27597779,CAN,AB,Calgary,72.29.251.209,MINOCYCLINE IS A TETRACYCLINE DERIVATIVE treats ACNE VULGARIS,73,0,,85,40,treats,0.98058067569092,907990-FS1-2,MINOCYCLINE IS A TETRACYCLINE DERIVATIVE mainly used in the treatment of ACNE VULGARIS in young persons.,ACNE VULGARIS,MINOCYCLINE IS A TETRACYCLINE DERIVATIVE,RO-may_treat
503007629,7/14/2014 21:45:01,,1323120637,7/14/2014 21:44:49,prodege,0.5819,2143114,CAN,BC,Vancouver,24.84.160.12,MINOCYCLINE IS A TETRACYCLINE DERIVATIVE treats ACNE VULGARIS,73,0,,85,40,treats,0.98058067569092,907990-FS1-2,MINOCYCLINE IS A TETRACYCLINE DERIVATIVE mainly used in the treatment of ACNE VULGARIS in young persons.,ACNE VULGARIS,MINOCYCLINE IS A TETRACYCLINE DERIVATIVE,RO-may_treat
503007629,7/14/2014 22:07:49,,1323132654,7/14/2014 22:07:32,instagc,0.5915,18960682,GBR,"","",86.29.147.112,MINOCYCLINE IS A TETRACYCLINE DERIVATIVE treats ACNE VULGARIS,73,0,,85,40,treats,0.98058067569092,907990-FS1-2,MINOCYCLINE IS A TETRACYCLINE DERIVATIVE mainly used in the treatment of ACNE VULGARIS in young persons.,ACNE VULGARIS,MINOCYCLINE IS A TETRACYCLINE DERIVATIVE,RO-may_treat
503007630,7/14/2014 20:33:25,,1323082415,7/14/2014 20:33:07,clixsense,0.9583,27871219,NLD,07,Amsterdam,87.210.207.223,MIDDLE EAR is location of ACUTE OTITIS MEDIA,94,27,,103,45,is location of,0.976187060183953,905496-FS1-9,The role of antibiotics in ACUTE OTITIS MEDIA is to eradicate the causative pathogen from the MIDDLE EAR,MIDDLE EAR,ACUTE OTITIS MEDIA,RO-has_finding_site
503007630,7/14/2014 20:41:25,,1323086460,7/14/2014 20:41:04,elite,0.875,28503042,USA,NJ,Woodbridge,54.191.150.115,no_relation,94,27,,103,45,is location of,0.976187060183953,905496-FS1-9,The role of antibiotics in ACUTE OTITIS MEDIA is to eradicate the causative pathogen from the MIDDLE EAR,MIDDLE EAR,ACUTE OTITIS MEDIA,RO-has_finding_site
503007630,7/14/2014 21:44:37,,1323120385,7/14/2014 21:44:21,neodev,0.6153,27597779,CAN,AB,Calgary,72.29.251.209,MIDDLE EAR is location of ACUTE OTITIS MEDIA,94,27,,103,45,is location of,0.976187060183953,905496-FS1-9,The role of antibiotics in ACUTE OTITIS MEDIA is to eradicate the causative pathogen from the MIDDLE EAR,MIDDLE EAR,ACUTE OTITIS MEDIA,RO-has_finding_site
503007630,7/14/2014 21:45:30,,1323121026,7/14/2014 21:44:24,clixsense,0.6786,13328793,GBR,G5,Maidstone,2.103.33.237,no_relation,94,27,,103,45,is location of,0.976187060183953,905496-FS1-9,The role of antibiotics in ACUTE OTITIS MEDIA is to eradicate the causative pathogen from the MIDDLE EAR,MIDDLE EAR,ACUTE OTITIS MEDIA,RO-has_finding_site
503007630,7/14/2014 22:07:49,,1323132653,7/14/2014 22:07:32,instagc,0.5915,18960682,GBR,"","",86.29.147.112,MIDDLE EAR is location of ACUTE OTITIS MEDIA,94,27,,103,45,is location of,0.976187060183953,905496-FS1-9,The role of antibiotics in ACUTE OTITIS MEDIA is to eradicate the causative pathogen from the MIDDLE EAR,MIDDLE EAR,ACUTE OTITIS MEDIA,RO-has_finding_site
503007630,7/14/2014 22:29:55,,1323145978,7/14/2014 22:29:20,clixsense,0.5752,15189335,GBR,K3,Peterborough,81.156.166.189,MIDDLE EAR is location of ACUTE OTITIS MEDIA,94,27,,103,45,is location of,0.976187060183953,905496-FS1-9,The role of antibiotics in ACUTE OTITIS MEDIA is to eradicate the causative pathogen from the MIDDLE EAR,MIDDLE EAR,ACUTE OTITIS MEDIA,RO-has_finding_site
503007630,7/14/2014 22:32:26,,1323147079,7/14/2014 22:32:21,clixsense,0.3016,25419319,GBR,H8,Liverpool,94.4.192.228,MIDDLE EAR is location of ACUTE OTITIS MEDIA,94,27,,103,45,is location of,0.976187060183953,905496-FS1-9,The role of antibiotics in ACUTE OTITIS MEDIA is to eradicate the causative pathogen from the MIDDLE EAR,MIDDLE EAR,ACUTE OTITIS MEDIA,RO-has_finding_site
503007631,7/14/2014 20:35:14,,1323083258,7/14/2014 20:34:47,neodev,0.9583,21515166,NLD,11,Nootdorp,83.86.58.179,RENAL OSTEODYSTROPHY causes END STAGE RENAL DISEASE (ESRD),107,167,,126,197,causes,0.771516749810459,900407-FS1-4,The purpose of the present study is to investigate whether an ethnic difference exists in the incidence of RENAL OSTEODYSTROPHY between Asian and Western countries in END STAGE RENAL DISEASE (ESRD) patients.,RENAL OSTEODYSTROPHY,END STAGE RENAL DISEASE (ESRD),RO-cause_of
503007631,7/14/2014 20:45:56,,1323088656,7/14/2014 20:45:52,instagc,0.6111,25990856,USA,NV,Las Vegas,68.108.98.78,RENAL OSTEODYSTROPHY causes END STAGE RENAL DISEASE (ESRD),107,167,,126,197,causes,0.771516749810459,900407-FS1-4,The purpose of the present study is to investigate whether an ethnic difference exists in the incidence of RENAL OSTEODYSTROPHY between Asian and Western countries in END STAGE RENAL DISEASE (ESRD) patients.,RENAL OSTEODYSTROPHY,END STAGE RENAL DISEASE (ESRD),RO-cause_of
503007631,7/14/2014 21:22:57,,1323106901,7/14/2014 21:22:15,prodege,0.7639,28255346,GBR,L9,Sheffield,2.125.183.137,END STAGE RENAL DISEASE (ESRD) causes RENAL OSTEODYSTROPHY,107,167,,126,197,causes,0.771516749810459,900407-FS1-4,The purpose of the present study is to investigate whether an ethnic difference exists in the incidence of RENAL OSTEODYSTROPHY between Asian and Western countries in END STAGE RENAL DISEASE (ESRD) patients.,RENAL OSTEODYSTROPHY,END STAGE RENAL DISEASE (ESRD),RO-cause_of
503007631,7/14/2014 21:27:02,,1323109031,7/14/2014 21:26:43,prodege,0.7306,23541832,USA,AZ,Tempe,149.169.129.225,no_relation,107,167,,126,197,causes,0.771516749810459,900407-FS1-4,The purpose of the present study is to investigate whether an ethnic difference exists in the incidence of RENAL OSTEODYSTROPHY between Asian and Western countries in END STAGE RENAL DISEASE (ESRD) patients.,RENAL OSTEODYSTROPHY,END STAGE RENAL DISEASE (ESRD),RO-cause_of
503007631,7/14/2014 21:49:26,,1323123664,7/14/2014 21:49:07,clixsense,0.5155,26889820,GBR,C3,Shelford,92.18.120.203,no_relation,107,167,,126,197,causes,0.771516749810459,900407-FS1-4,The purpose of the present study is to investigate whether an ethnic difference exists in the incidence of RENAL OSTEODYSTROPHY between Asian and Western countries in END STAGE RENAL DISEASE (ESRD) patients.,RENAL OSTEODYSTROPHY,END STAGE RENAL DISEASE (ESRD),RO-cause_of
503007631,7/14/2014 22:28:28,,1323145364,7/14/2014 22:28:13,clixsense,0.5752,15189335,GBR,K3,Peterborough,81.156.166.189,RENAL OSTEODYSTROPHY causes END STAGE RENAL DISEASE (ESRD),107,167,,126,197,causes,0.771516749810459,900407-FS1-4,The purpose of the present study is to investigate whether an ethnic difference exists in the incidence of RENAL OSTEODYSTROPHY between Asian and Western countries in END STAGE RENAL DISEASE (ESRD) patients.,RENAL OSTEODYSTROPHY,END STAGE RENAL DISEASE (ESRD),RO-cause_of
503007631,7/14/2014 22:30:47,,1323146325,7/14/2014 22:30:31,instagc,0.5867,23149109,USA,NC,Durham,75.189.206.205,END STAGE RENAL DISEASE (ESRD) causes RENAL OSTEODYSTROPHY,107,167,,126,197,causes,0.771516749810459,900407-FS1-4,The purpose of the present study is to investigate whether an ethnic difference exists in the incidence of RENAL OSTEODYSTROPHY between Asian and Western countries in END STAGE RENAL DISEASE (ESRD) patients.,RENAL OSTEODYSTROPHY,END STAGE RENAL DISEASE (ESRD),RO-cause_of
503007632,7/14/2014 20:49:38,,1323090600,7/14/2014 20:49:23,zoombucks,0.875,28232452,USA,NC,Cary,174.97.217.113,no_relation,139,157,,146,163,causes,0.800640769025436,907665-FS1-4,Deficiency diseases include night blindness and keratomalacia (caused by lack of vitamin A); beriberi and polyneuritis (lack of thiamine); PELLAGRA (lack of NIACIN); scurvy (lack of vitamin C); rickets and osteomalacia (lack of vitamin D); pernicious anemia (lack of gastric intrinsic factor and vitamin B 12.,PELLAGRA,NIACIN,RO-may_treat
503007632,7/14/2014 21:24:28,,1323107649,7/14/2014 21:24:18,clixsense,0.5625,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,139,157,,146,163,causes,0.800640769025436,907665-FS1-4,Deficiency diseases include night blindness and keratomalacia (caused by lack of vitamin A); beriberi and polyneuritis (lack of thiamine); PELLAGRA (lack of NIACIN); scurvy (lack of vitamin C); rickets and osteomalacia (lack of vitamin D); pernicious anemia (lack of gastric intrinsic factor and vitamin B 12.,PELLAGRA,NIACIN,RO-may_treat
503007632,7/14/2014 21:37:34,,1323114899,7/14/2014 21:37:28,clixsense,0.4925,19162475,GBR,M3,Frome,82.33.126.30,NIACIN causes PELLAGRA,139,157,,146,163,causes,0.800640769025436,907665-FS1-4,Deficiency diseases include night blindness and keratomalacia (caused by lack of vitamin A); beriberi and polyneuritis (lack of thiamine); PELLAGRA (lack of NIACIN); scurvy (lack of vitamin C); rickets and osteomalacia (lack of vitamin D); pernicious anemia (lack of gastric intrinsic factor and vitamin B 12.,PELLAGRA,NIACIN,RO-may_treat
503007632,7/14/2014 21:44:24,,1323120072,7/14/2014 21:44:12,prodege,0.5819,2143114,CAN,BC,Vancouver,24.84.160.12,PELLAGRA causes NIACIN,139,157,,146,163,causes,0.800640769025436,907665-FS1-4,Deficiency diseases include night blindness and keratomalacia (caused by lack of vitamin A); beriberi and polyneuritis (lack of thiamine); PELLAGRA (lack of NIACIN); scurvy (lack of vitamin C); rickets and osteomalacia (lack of vitamin D); pernicious anemia (lack of gastric intrinsic factor and vitamin B 12.,PELLAGRA,NIACIN,RO-may_treat
503007632,7/14/2014 21:46:15,,1323121600,7/14/2014 21:45:23,neodev,0.6153,27597779,CAN,AB,Calgary,72.29.251.209,no_relation,139,157,,146,163,causes,0.800640769025436,907665-FS1-4,Deficiency diseases include night blindness and keratomalacia (caused by lack of vitamin A); beriberi and polyneuritis (lack of thiamine); PELLAGRA (lack of NIACIN); scurvy (lack of vitamin C); rickets and osteomalacia (lack of vitamin D); pernicious anemia (lack of gastric intrinsic factor and vitamin B 12.,PELLAGRA,NIACIN,RO-may_treat
503007632,7/14/2014 21:49:26,,1323123665,7/14/2014 21:49:07,clixsense,0.5155,26889820,GBR,C3,Shelford,92.18.120.203,no_relation,139,157,,146,163,causes,0.800640769025436,907665-FS1-4,Deficiency diseases include night blindness and keratomalacia (caused by lack of vitamin A); beriberi and polyneuritis (lack of thiamine); PELLAGRA (lack of NIACIN); scurvy (lack of vitamin C); rickets and osteomalacia (lack of vitamin D); pernicious anemia (lack of gastric intrinsic factor and vitamin B 12.,PELLAGRA,NIACIN,RO-may_treat
503007632,7/14/2014 22:08:26,,1323133044,7/14/2014 22:08:08,instagc,0.5915,18960682,GBR,"","",86.29.147.112,no_relation,139,157,,146,163,causes,0.800640769025436,907665-FS1-4,Deficiency diseases include night blindness and keratomalacia (caused by lack of vitamin A); beriberi and polyneuritis (lack of thiamine); PELLAGRA (lack of NIACIN); scurvy (lack of vitamin C); rickets and osteomalacia (lack of vitamin D); pernicious anemia (lack of gastric intrinsic factor and vitamin B 12.,PELLAGRA,NIACIN,RO-may_treat
503007633,7/14/2014 20:34:10,,1323082730,7/14/2014 20:33:45,neodev,0.9583,21515166,NLD,11,Nootdorp,83.86.58.179,DEMENTIA WITH LEWY BODIES causes PARKINSONISM,209,152,,220,177,causes,0.755928946018454,906069-FS1-4,"Typically, but not invariably, dementia precedes or accompanies the onset of parkinsonism  Three or more major or minor criteria suggest a diagnosis of DEMENTIA WITH LEWY BODIES (&gt;75% sensitivity) Vascular PARKINSONISM  Also known as lower body parkinsonism.",PARKINSONISM,DEMENTIA WITH LEWY BODIES,RO-has_manifestation
503007633,7/14/2014 21:13:08,,1323102566,7/14/2014 21:12:39,elite,0.8694,28276268,USA,MI,Taylor,67.149.247.166,DEMENTIA WITH LEWY BODIES causes PARKINSONISM,209,152,,220,177,causes,0.755928946018454,906069-FS1-4,"Typically, but not invariably, dementia precedes or accompanies the onset of parkinsonism  Three or more major or minor criteria suggest a diagnosis of DEMENTIA WITH LEWY BODIES (&gt;75% sensitivity) Vascular PARKINSONISM  Also known as lower body parkinsonism.",PARKINSONISM,DEMENTIA WITH LEWY BODIES,RO-has_manifestation
503007633,7/14/2014 21:24:01,,1323107435,7/14/2014 21:23:50,clixsense,0.5625,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,209,152,,220,177,causes,0.755928946018454,906069-FS1-4,"Typically, but not invariably, dementia precedes or accompanies the onset of parkinsonism  Three or more major or minor criteria suggest a diagnosis of DEMENTIA WITH LEWY BODIES (&gt;75% sensitivity) Vascular PARKINSONISM  Also known as lower body parkinsonism.",PARKINSONISM,DEMENTIA WITH LEWY BODIES,RO-has_manifestation
503007633,7/14/2014 21:39:33,,1323116226,7/14/2014 21:39:13,instagc,0.7958,28301350,GBR,K4,Plymouth,92.28.215.248,no_relation,209,152,,220,177,causes,0.755928946018454,906069-FS1-4,"Typically, but not invariably, dementia precedes or accompanies the onset of parkinsonism  Three or more major or minor criteria suggest a diagnosis of DEMENTIA WITH LEWY BODIES (&gt;75% sensitivity) Vascular PARKINSONISM  Also known as lower body parkinsonism.",PARKINSONISM,DEMENTIA WITH LEWY BODIES,RO-has_manifestation
503007633,7/14/2014 21:46:15,,1323121607,7/14/2014 21:45:23,neodev,0.6153,27597779,CAN,AB,Calgary,72.29.251.209,no_relation,209,152,,220,177,causes,0.755928946018454,906069-FS1-4,"Typically, but not invariably, dementia precedes or accompanies the onset of parkinsonism  Three or more major or minor criteria suggest a diagnosis of DEMENTIA WITH LEWY BODIES (&gt;75% sensitivity) Vascular PARKINSONISM  Also known as lower body parkinsonism.",PARKINSONISM,DEMENTIA WITH LEWY BODIES,RO-has_manifestation
503007633,7/14/2014 21:50:10,,1323124018,7/14/2014 21:49:28,clixsense,0.5155,26889820,GBR,C3,Shelford,92.18.120.203,no_relation,209,152,,220,177,causes,0.755928946018454,906069-FS1-4,"Typically, but not invariably, dementia precedes or accompanies the onset of parkinsonism  Three or more major or minor criteria suggest a diagnosis of DEMENTIA WITH LEWY BODIES (&gt;75% sensitivity) Vascular PARKINSONISM  Also known as lower body parkinsonism.",PARKINSONISM,DEMENTIA WITH LEWY BODIES,RO-has_manifestation
503007633,7/14/2014 22:08:07,,1323132829,7/14/2014 22:07:51,instagc,0.5915,18960682,GBR,"","",86.29.147.112,no_relation,209,152,,220,177,causes,0.755928946018454,906069-FS1-4,"Typically, but not invariably, dementia precedes or accompanies the onset of parkinsonism  Three or more major or minor criteria suggest a diagnosis of DEMENTIA WITH LEWY BODIES (&gt;75% sensitivity) Vascular PARKINSONISM  Also known as lower body parkinsonism.",PARKINSONISM,DEMENTIA WITH LEWY BODIES,RO-has_manifestation
503007634,7/14/2014 20:42:40,,1323086984,7/14/2014 20:41:50,elite,0.875,28503042,USA,NJ,Woodbridge,54.191.150.115,ASCITES is location of OVARIAN MUCINOUS ADENOCARCINOMAS,141,63,,147,95,is location of,0.707106781186547,902909-FS1-9,"On cytology it was found that cancer cells in the ascites from OVARIAN MUCINOUS ADENOCARCINOMAS were HNF4 alpha positive, but tumor cells in ASCITES from other types of ovarian carcinomas were negative for HNF4 alpha.",ASCITES,OVARIAN MUCINOUS ADENOCARCINOMAS,RO-disease_may_have_finding
503007634,7/14/2014 21:10:37,,1323101463,7/14/2014 21:10:10,prodege,0.7306,23541832,USA,AZ,Tempe,149.169.129.225,OVARIAN MUCINOUS ADENOCARCINOMAS is location of ASCITES,141,63,,147,95,is location of,0.707106781186547,902909-FS1-9,"On cytology it was found that cancer cells in the ascites from OVARIAN MUCINOUS ADENOCARCINOMAS were HNF4 alpha positive, but tumor cells in ASCITES from other types of ovarian carcinomas were negative for HNF4 alpha.",ASCITES,OVARIAN MUCINOUS ADENOCARCINOMAS,RO-disease_may_have_finding
503007634,7/14/2014 21:14:11,,1323103025,7/14/2014 21:13:49,elite,0.8694,28276268,USA,MI,Taylor,67.149.247.166,OVARIAN MUCINOUS ADENOCARCINOMAS is location of ASCITES,141,63,,147,95,is location of,0.707106781186547,902909-FS1-9,"On cytology it was found that cancer cells in the ascites from OVARIAN MUCINOUS ADENOCARCINOMAS were HNF4 alpha positive, but tumor cells in ASCITES from other types of ovarian carcinomas were negative for HNF4 alpha.",ASCITES,OVARIAN MUCINOUS ADENOCARCINOMAS,RO-disease_may_have_finding
503007634,7/14/2014 21:30:07,,1323110795,7/14/2014 21:29:11,instagc,0.6498,19602039,USA,WA,Bellevue,50.135.214.140,no_relation,141,63,,147,95,is location of,0.707106781186547,902909-FS1-9,"On cytology it was found that cancer cells in the ascites from OVARIAN MUCINOUS ADENOCARCINOMAS were HNF4 alpha positive, but tumor cells in ASCITES from other types of ovarian carcinomas were negative for HNF4 alpha.",ASCITES,OVARIAN MUCINOUS ADENOCARCINOMAS,RO-disease_may_have_finding
503007634,7/14/2014 21:35:54,,1323113925,7/14/2014 21:35:30,clixsense,0.5974,19803139,NLD,06,Veldhoven,212.61.84.196,ASCITES is location of OVARIAN MUCINOUS ADENOCARCINOMAS,141,63,,147,95,is location of,0.707106781186547,902909-FS1-9,"On cytology it was found that cancer cells in the ascites from OVARIAN MUCINOUS ADENOCARCINOMAS were HNF4 alpha positive, but tumor cells in ASCITES from other types of ovarian carcinomas were negative for HNF4 alpha.",ASCITES,OVARIAN MUCINOUS ADENOCARCINOMAS,RO-disease_may_have_finding
503007634,7/14/2014 21:37:13,,1323114654,7/14/2014 21:37:07,clixsense,0.4925,19162475,GBR,M3,Frome,82.33.126.30,OVARIAN MUCINOUS ADENOCARCINOMAS is location of ASCITES,141,63,,147,95,is location of,0.707106781186547,902909-FS1-9,"On cytology it was found that cancer cells in the ascites from OVARIAN MUCINOUS ADENOCARCINOMAS were HNF4 alpha positive, but tumor cells in ASCITES from other types of ovarian carcinomas were negative for HNF4 alpha.",ASCITES,OVARIAN MUCINOUS ADENOCARCINOMAS,RO-disease_may_have_finding
503007634,7/14/2014 21:50:59,,1323124397,7/14/2014 21:50:12,clixsense,0.5155,26889820,GBR,C3,Shelford,92.18.120.203,no_relation,141,63,,147,95,is location of,0.707106781186547,902909-FS1-9,"On cytology it was found that cancer cells in the ascites from OVARIAN MUCINOUS ADENOCARCINOMAS were HNF4 alpha positive, but tumor cells in ASCITES from other types of ovarian carcinomas were negative for HNF4 alpha.",ASCITES,OVARIAN MUCINOUS ADENOCARCINOMAS,RO-disease_may_have_finding
503007635,7/14/2014 20:42:40,,1323086991,7/14/2014 20:41:50,elite,0.875,28503042,USA,NJ,Woodbridge,54.191.150.115,no_relation,63,208,,80,228,diagnosed by,0.937042571331636,902099-FS1-13,"In conclusion, NSE was considered to be very useful as a tumor MARKER OF THE LUNG especially in small cell carcinoma for diagnosis and determination of disease extent and response to therapy, and also in non SMALL CELL CARCINOMA for the evaluation of treatment effectiveness.",MARKER OF THE LUNG,SMALL CELL CARCINOMA,RO-disease_has_primary_anatomic_site
503007635,7/14/2014 21:23:37,,1323107251,7/14/2014 21:23:27,clixsense,0.5625,16827630,GBR,A7,Birmingham,86.146.169.103,SMALL CELL CARCINOMA diagnosed by MARKER OF THE LUNG,63,208,,80,228,diagnosed by,0.937042571331636,902099-FS1-13,"In conclusion, NSE was considered to be very useful as a tumor MARKER OF THE LUNG especially in small cell carcinoma for diagnosis and determination of disease extent and response to therapy, and also in non SMALL CELL CARCINOMA for the evaluation of treatment effectiveness.",MARKER OF THE LUNG,SMALL CELL CARCINOMA,RO-disease_has_primary_anatomic_site
503007635,7/14/2014 21:26:16,,1323108639,7/14/2014 21:26:06,prodege,0.7306,23541832,USA,AZ,Tempe,149.169.129.225,SMALL CELL CARCINOMA diagnosed by MARKER OF THE LUNG,63,208,,80,228,diagnosed by,0.937042571331636,902099-FS1-13,"In conclusion, NSE was considered to be very useful as a tumor MARKER OF THE LUNG especially in small cell carcinoma for diagnosis and determination of disease extent and response to therapy, and also in non SMALL CELL CARCINOMA for the evaluation of treatment effectiveness.",MARKER OF THE LUNG,SMALL CELL CARCINOMA,RO-disease_has_primary_anatomic_site
503007635,7/14/2014 21:30:07,,1323110806,7/14/2014 21:29:11,instagc,0.6498,19602039,USA,WA,Bellevue,50.135.214.140,no_relation,63,208,,80,228,diagnosed by,0.937042571331636,902099-FS1-13,"In conclusion, NSE was considered to be very useful as a tumor MARKER OF THE LUNG especially in small cell carcinoma for diagnosis and determination of disease extent and response to therapy, and also in non SMALL CELL CARCINOMA for the evaluation of treatment effectiveness.",MARKER OF THE LUNG,SMALL CELL CARCINOMA,RO-disease_has_primary_anatomic_site
503007635,7/14/2014 21:37:20,,1323114750,7/14/2014 21:37:14,clixsense,0.4925,19162475,GBR,M3,Frome,82.33.126.30,SMALL CELL CARCINOMA diagnosed by MARKER OF THE LUNG,63,208,,80,228,diagnosed by,0.937042571331636,902099-FS1-13,"In conclusion, NSE was considered to be very useful as a tumor MARKER OF THE LUNG especially in small cell carcinoma for diagnosis and determination of disease extent and response to therapy, and also in non SMALL CELL CARCINOMA for the evaluation of treatment effectiveness.",MARKER OF THE LUNG,SMALL CELL CARCINOMA,RO-disease_has_primary_anatomic_site
503007635,7/14/2014 21:44:20,,1323120010,7/14/2014 21:44:00,neodev,0.6153,27597779,CAN,AB,Calgary,72.29.251.209,no_relation,63,208,,80,228,diagnosed by,0.937042571331636,902099-FS1-13,"In conclusion, NSE was considered to be very useful as a tumor MARKER OF THE LUNG especially in small cell carcinoma for diagnosis and determination of disease extent and response to therapy, and also in non SMALL CELL CARCINOMA for the evaluation of treatment effectiveness.",MARKER OF THE LUNG,SMALL CELL CARCINOMA,RO-disease_has_primary_anatomic_site
503007635,7/14/2014 22:29:18,,1323145694,7/14/2014 22:28:30,clixsense,0.5752,15189335,GBR,K3,Peterborough,81.156.166.189,SMALL CELL CARCINOMA diagnosed by MARKER OF THE LUNG,63,208,,80,228,diagnosed by,0.937042571331636,902099-FS1-13,"In conclusion, NSE was considered to be very useful as a tumor MARKER OF THE LUNG especially in small cell carcinoma for diagnosis and determination of disease extent and response to therapy, and also in non SMALL CELL CARCINOMA for the evaluation of treatment effectiveness.",MARKER OF THE LUNG,SMALL CELL CARCINOMA,RO-disease_has_primary_anatomic_site
503007636,7/14/2014 20:34:15,,1323082799,7/14/2014 20:33:57,clixsense,0.9583,27871219,NLD,07,Amsterdam,87.210.207.223,PROMETHAZINE treats VOMITING,82,147,,89,159,treats,0.925820099772551,907661-FS1-2,"Prochlorperazine was more effective than promethazine in uncomplicated nausea and VOMITING in the emergency department  Keywords: Prochlorperazine PROMETHAZINE Treatment, emergency.",VOMITING,PROMETHAZINE,RO-may_treat
503007636,7/14/2014 20:34:29,,1323082950,7/14/2014 20:34:11,neodev,0.9583,21515166,NLD,11,Nootdorp,83.86.58.179,PROMETHAZINE treats VOMITING,82,147,,89,159,treats,0.925820099772551,907661-FS1-2,"Prochlorperazine was more effective than promethazine in uncomplicated nausea and VOMITING in the emergency department  Keywords: Prochlorperazine PROMETHAZINE Treatment, emergency.",VOMITING,PROMETHAZINE,RO-may_treat
503007636,7/14/2014 20:45:51,,1323088607,7/14/2014 20:45:48,instagc,0.6111,25990856,USA,NV,Las Vegas,68.108.98.78,VOMITING treats PROMETHAZINE,82,147,,89,159,treats,0.925820099772551,907661-FS1-2,"Prochlorperazine was more effective than promethazine in uncomplicated nausea and VOMITING in the emergency department  Keywords: Prochlorperazine PROMETHAZINE Treatment, emergency.",VOMITING,PROMETHAZINE,RO-may_treat
503007636,7/14/2014 21:22:57,,1323106900,7/14/2014 21:22:15,prodege,0.7639,28255346,GBR,L9,Sheffield,2.125.183.137,PROMETHAZINE treats VOMITING,82,147,,89,159,treats,0.925820099772551,907661-FS1-2,"Prochlorperazine was more effective than promethazine in uncomplicated nausea and VOMITING in the emergency department  Keywords: Prochlorperazine PROMETHAZINE Treatment, emergency.",VOMITING,PROMETHAZINE,RO-may_treat
503007636,7/14/2014 21:26:41,,1323108866,7/14/2014 21:26:27,prodege,0.7306,23541832,USA,AZ,Tempe,149.169.129.225,PROMETHAZINE treats VOMITING,82,147,,89,159,treats,0.925820099772551,907661-FS1-2,"Prochlorperazine was more effective than promethazine in uncomplicated nausea and VOMITING in the emergency department  Keywords: Prochlorperazine PROMETHAZINE Treatment, emergency.",VOMITING,PROMETHAZINE,RO-may_treat
503007636,7/14/2014 21:37:29,,1323114866,7/14/2014 21:37:06,clixsense,0.5974,19803139,NLD,06,Veldhoven,212.61.84.196,PROMETHAZINE treats VOMITING,82,147,,89,159,treats,0.925820099772551,907661-FS1-2,"Prochlorperazine was more effective than promethazine in uncomplicated nausea and VOMITING in the emergency department  Keywords: Prochlorperazine PROMETHAZINE Treatment, emergency.",VOMITING,PROMETHAZINE,RO-may_treat
503007636,7/14/2014 21:37:47,,1323115015,7/14/2014 21:37:41,clixsense,0.4925,19162475,GBR,M3,Frome,82.33.126.30,PROMETHAZINE treats VOMITING,82,147,,89,159,treats,0.925820099772551,907661-FS1-2,"Prochlorperazine was more effective than promethazine in uncomplicated nausea and VOMITING in the emergency department  Keywords: Prochlorperazine PROMETHAZINE Treatment, emergency.",VOMITING,PROMETHAZINE,RO-may_treat
503007637,7/14/2014 20:32:47,,1323082104,7/14/2014 20:32:15,clixsense,0.9583,27871219,NLD,07,Amsterdam,87.210.207.223,DIC causes APL,79,3,,81,6,causes,0.328797974610715,902646-FS1-4,"In APL with the translocation t(15;17), all  trans  retinoic acid corrects the DIC in 2 to 5 days; combined with daunorubicin or idarubicin, this regimen can induce remission in 80 to 90% of patients, and long term survival in 65 to 70%.",DIC,APL,RO-disease_may_have_finding
503007637,7/14/2014 21:13:47,,1323102829,7/14/2014 21:13:10,elite,0.8694,28276268,USA,MI,Taylor,67.149.247.166,APL causes DIC,79,3,,81,6,causes,0.328797974610715,902646-FS1-4,"In APL with the translocation t(15;17), all  trans  retinoic acid corrects the DIC in 2 to 5 days; combined with daunorubicin or idarubicin, this regimen can induce remission in 80 to 90% of patients, and long term survival in 65 to 70%.",DIC,APL,RO-disease_may_have_finding
503007637,7/14/2014 21:33:05,,1323112406,7/14/2014 21:32:45,tremorgames,0.5903,28013393,USA,CA,Rancho Cordova,71.197.67.37,APL causes DIC,79,3,,81,6,causes,0.328797974610715,902646-FS1-4,"In APL with the translocation t(15;17), all  trans  retinoic acid corrects the DIC in 2 to 5 days; combined with daunorubicin or idarubicin, this regimen can induce remission in 80 to 90% of patients, and long term survival in 65 to 70%.",DIC,APL,RO-disease_may_have_finding
503007637,7/14/2014 21:39:58,,1323116459,7/14/2014 21:39:34,instagc,0.7958,28301350,GBR,K4,Plymouth,92.28.215.248,no_relation,79,3,,81,6,causes,0.328797974610715,902646-FS1-4,"In APL with the translocation t(15;17), all  trans  retinoic acid corrects the DIC in 2 to 5 days; combined with daunorubicin or idarubicin, this regimen can induce remission in 80 to 90% of patients, and long term survival in 65 to 70%.",DIC,APL,RO-disease_may_have_finding
503007637,7/14/2014 21:45:22,,1323120902,7/14/2014 21:44:38,neodev,0.6153,27597779,CAN,AB,Calgary,72.29.251.209,no_relation,79,3,,81,6,causes,0.328797974610715,902646-FS1-4,"In APL with the translocation t(15;17), all  trans  retinoic acid corrects the DIC in 2 to 5 days; combined with daunorubicin or idarubicin, this regimen can induce remission in 80 to 90% of patients, and long term survival in 65 to 70%.",DIC,APL,RO-disease_may_have_finding
503007637,7/14/2014 22:30:47,,1323146324,7/14/2014 22:30:31,instagc,0.5867,23149109,USA,NC,Durham,75.189.206.205,APL causes DIC,79,3,,81,6,causes,0.328797974610715,902646-FS1-4,"In APL with the translocation t(15;17), all  trans  retinoic acid corrects the DIC in 2 to 5 days; combined with daunorubicin or idarubicin, this regimen can induce remission in 80 to 90% of patients, and long term survival in 65 to 70%.",DIC,APL,RO-disease_may_have_finding
503007637,7/14/2014 22:32:15,,1323146976,7/14/2014 22:32:10,clixsense,0.3016,25419319,GBR,H8,Liverpool,94.4.192.228,DIC causes APL,79,3,,81,6,causes,0.328797974610715,902646-FS1-4,"In APL with the translocation t(15;17), all  trans  retinoic acid corrects the DIC in 2 to 5 days; combined with daunorubicin or idarubicin, this regimen can induce remission in 80 to 90% of patients, and long term survival in 65 to 70%.",DIC,APL,RO-disease_may_have_finding
503007638,7/14/2014 20:33:55,,1323082641,7/14/2014 20:33:26,clixsense,0.9583,27871219,NLD,07,Amsterdam,87.210.207.223,PARKINSONISM diagnosed by DEMENTIA WITH LEWY BODIES,209,152,,220,177,diagnosed by,0.377964473009227,906069-FS1-13,"Typically, but not invariably, dementia precedes or accompanies the onset of parkinsonism  Three or more major or minor criteria suggest a diagnosis of DEMENTIA WITH LEWY BODIES (&gt;75% sensitivity) Vascular PARKINSONISM  Also known as lower body parkinsonism.",PARKINSONISM,DEMENTIA WITH LEWY BODIES,RO-has_manifestation
503007638,7/14/2014 20:43:23,,1323087349,7/14/2014 20:42:57,elite,0.875,28503042,USA,NJ,Woodbridge,54.191.150.115,no_relation,209,152,,220,177,diagnosed by,0.377964473009227,906069-FS1-13,"Typically, but not invariably, dementia precedes or accompanies the onset of parkinsonism  Three or more major or minor criteria suggest a diagnosis of DEMENTIA WITH LEWY BODIES (&gt;75% sensitivity) Vascular PARKINSONISM  Also known as lower body parkinsonism.",PARKINSONISM,DEMENTIA WITH LEWY BODIES,RO-has_manifestation
503007638,7/14/2014 20:45:42,,1323088467,7/14/2014 20:45:21,instagc,0.6111,25990856,USA,NV,Las Vegas,68.108.98.78,PARKINSONISM diagnosed by DEMENTIA WITH LEWY BODIES,209,152,,220,177,diagnosed by,0.377964473009227,906069-FS1-13,"Typically, but not invariably, dementia precedes or accompanies the onset of parkinsonism  Three or more major or minor criteria suggest a diagnosis of DEMENTIA WITH LEWY BODIES (&gt;75% sensitivity) Vascular PARKINSONISM  Also known as lower body parkinsonism.",PARKINSONISM,DEMENTIA WITH LEWY BODIES,RO-has_manifestation
503007638,7/14/2014 20:47:53,,1323089612,7/14/2014 20:47:07,zoombucks,0.875,28232452,USA,NC,Cary,174.97.217.113,no_relation,209,152,,220,177,diagnosed by,0.377964473009227,906069-FS1-13,"Typically, but not invariably, dementia precedes or accompanies the onset of parkinsonism  Three or more major or minor criteria suggest a diagnosis of DEMENTIA WITH LEWY BODIES (&gt;75% sensitivity) Vascular PARKINSONISM  Also known as lower body parkinsonism.",PARKINSONISM,DEMENTIA WITH LEWY BODIES,RO-has_manifestation
503007638,7/14/2014 21:33:05,,1323112410,7/14/2014 21:32:45,tremorgames,0.5903,28013393,USA,CA,Rancho Cordova,71.197.67.37,DEMENTIA WITH LEWY BODIES diagnosed by PARKINSONISM,209,152,,220,177,diagnosed by,0.377964473009227,906069-FS1-13,"Typically, but not invariably, dementia precedes or accompanies the onset of parkinsonism  Three or more major or minor criteria suggest a diagnosis of DEMENTIA WITH LEWY BODIES (&gt;75% sensitivity) Vascular PARKINSONISM  Also known as lower body parkinsonism.",PARKINSONISM,DEMENTIA WITH LEWY BODIES,RO-has_manifestation
503007638,7/14/2014 21:35:15,,1323113556,7/14/2014 21:34:23,neodev,0.7333,18755947,GBR,H2,Accrington,80.47.185.52,no_relation,209,152,,220,177,diagnosed by,0.377964473009227,906069-FS1-13,"Typically, but not invariably, dementia precedes or accompanies the onset of parkinsonism  Three or more major or minor criteria suggest a diagnosis of DEMENTIA WITH LEWY BODIES (&gt;75% sensitivity) Vascular PARKINSONISM  Also known as lower body parkinsonism.",PARKINSONISM,DEMENTIA WITH LEWY BODIES,RO-has_manifestation
503007638,7/14/2014 21:37:26,,1323114841,7/14/2014 21:37:22,clixsense,0.4925,19162475,GBR,M3,Frome,82.33.126.30,DEMENTIA WITH LEWY BODIES diagnosed by PARKINSONISM,209,152,,220,177,diagnosed by,0.377964473009227,906069-FS1-13,"Typically, but not invariably, dementia precedes or accompanies the onset of parkinsonism  Three or more major or minor criteria suggest a diagnosis of DEMENTIA WITH LEWY BODIES (&gt;75% sensitivity) Vascular PARKINSONISM  Also known as lower body parkinsonism.",PARKINSONISM,DEMENTIA WITH LEWY BODIES,RO-has_manifestation
503007639,7/14/2014 20:33:44,,1323082577,7/14/2014 20:33:23,neodev,0.9583,21515166,NLD,11,Nootdorp,83.86.58.179,CADMIUM causes ITAI ITAI DISEASE,155,206,,161,223,causes,0.970142500145332,903720-FS1-4,"In view of these data, the length of cadmium exposure and the life span of animals as well as epidemiological data published elsewhere, factors other than CADMIUM may also be involved in the development of ITAI ITAI DISEASE.",CADMIUM,ITAI ITAI DISEASE,RO-has_causative_agent
503007639,7/14/2014 20:49:22,,1323090396,7/14/2014 20:49:01,zoombucks,0.875,28232452,USA,NC,Cary,174.97.217.113,CADMIUM causes ITAI ITAI DISEASE,155,206,,161,223,causes,0.970142500145332,903720-FS1-4,"In view of these data, the length of cadmium exposure and the life span of animals as well as epidemiological data published elsewhere, factors other than CADMIUM may also be involved in the development of ITAI ITAI DISEASE.",CADMIUM,ITAI ITAI DISEASE,RO-has_causative_agent
503007639,7/14/2014 21:24:16,,1323107560,7/14/2014 21:24:03,clixsense,0.5625,16827630,GBR,A7,Birmingham,86.146.169.103,CADMIUM causes ITAI ITAI DISEASE,155,206,,161,223,causes,0.970142500145332,903720-FS1-4,"In view of these data, the length of cadmium exposure and the life span of animals as well as epidemiological data published elsewhere, factors other than CADMIUM may also be involved in the development of ITAI ITAI DISEASE.",CADMIUM,ITAI ITAI DISEASE,RO-has_causative_agent
503007639,7/14/2014 21:30:53,,1323111224,7/14/2014 21:30:27,neodev,0.7333,18755947,GBR,H2,Accrington,80.47.185.52,CADMIUM causes ITAI ITAI DISEASE,155,206,,161,223,causes,0.970142500145332,903720-FS1-4,"In view of these data, the length of cadmium exposure and the life span of animals as well as epidemiological data published elsewhere, factors other than CADMIUM may also be involved in the development of ITAI ITAI DISEASE.",CADMIUM,ITAI ITAI DISEASE,RO-has_causative_agent
503007639,7/14/2014 21:37:54,,1323115129,7/14/2014 21:37:30,clixsense,0.5974,19803139,NLD,06,Veldhoven,212.61.84.196,CADMIUM causes ITAI ITAI DISEASE,155,206,,161,223,causes,0.970142500145332,903720-FS1-4,"In view of these data, the length of cadmium exposure and the life span of animals as well as epidemiological data published elsewhere, factors other than CADMIUM may also be involved in the development of ITAI ITAI DISEASE.",CADMIUM,ITAI ITAI DISEASE,RO-has_causative_agent
503007639,7/14/2014 21:39:12,,1323115981,7/14/2014 21:38:57,instagc,0.7958,28301350,GBR,K4,Plymouth,92.28.215.248,CADMIUM causes ITAI ITAI DISEASE,155,206,,161,223,causes,0.970142500145332,903720-FS1-4,"In view of these data, the length of cadmium exposure and the life span of animals as well as epidemiological data published elsewhere, factors other than CADMIUM may also be involved in the development of ITAI ITAI DISEASE.",CADMIUM,ITAI ITAI DISEASE,RO-has_causative_agent
503007639,7/14/2014 21:45:10,,1323120740,7/14/2014 21:45:03,prodege,0.5819,2143114,CAN,BC,Vancouver,24.84.160.12,CADMIUM causes ITAI ITAI DISEASE,155,206,,161,223,causes,0.970142500145332,903720-FS1-4,"In view of these data, the length of cadmium exposure and the life span of animals as well as epidemiological data published elsewhere, factors other than CADMIUM may also be involved in the development of ITAI ITAI DISEASE.",CADMIUM,ITAI ITAI DISEASE,RO-has_causative_agent
503007640,7/14/2014 20:47:53,,1323089611,7/14/2014 20:47:07,zoombucks,0.875,28232452,USA,NC,Cary,174.97.217.113,DYSMENORRHEA causes PAIN,196,136,,199,148,causes,0.811107105653813,904857-FS1-4,neosalpingostomy for symptomatic hydrosalpinx; 7) ovarian treatment for symptomatic ovarian pain; 8) uterosacral nerve vaporization for DYSMENORRHEA; 9) presacral neurectomy for disabling central PAIN primarily of uterine but also of bladder origin; 10) resection of endometriosis from all surfaces including removal from bladder and bowel as well as from the rectovaginal septal space.,PAIN,DYSMENORRHEA,RO-has_definitional_manifestation
503007640,7/14/2014 21:17:56,,1323104731,7/14/2014 21:17:03,prodege,0.7639,28255346,GBR,L9,Sheffield,2.125.183.137,DYSMENORRHEA causes PAIN,196,136,,199,148,causes,0.811107105653813,904857-FS1-4,neosalpingostomy for symptomatic hydrosalpinx; 7) ovarian treatment for symptomatic ovarian pain; 8) uterosacral nerve vaporization for DYSMENORRHEA; 9) presacral neurectomy for disabling central PAIN primarily of uterine but also of bladder origin; 10) resection of endometriosis from all surfaces including removal from bladder and bowel as well as from the rectovaginal septal space.,PAIN,DYSMENORRHEA,RO-has_definitional_manifestation
503007640,7/14/2014 21:32:39,,1323112141,7/14/2014 21:31:51,instagc,0.6498,19602039,USA,WA,Bellevue,50.135.214.140,DYSMENORRHEA causes PAIN,196,136,,199,148,causes,0.811107105653813,904857-FS1-4,neosalpingostomy for symptomatic hydrosalpinx; 7) ovarian treatment for symptomatic ovarian pain; 8) uterosacral nerve vaporization for DYSMENORRHEA; 9) presacral neurectomy for disabling central PAIN primarily of uterine but also of bladder origin; 10) resection of endometriosis from all surfaces including removal from bladder and bowel as well as from the rectovaginal septal space.,PAIN,DYSMENORRHEA,RO-has_definitional_manifestation
503007640,7/14/2014 21:40:17,,1323116761,7/14/2014 21:39:59,instagc,0.7958,28301350,GBR,K4,Plymouth,92.28.215.248,DYSMENORRHEA causes PAIN,196,136,,199,148,causes,0.811107105653813,904857-FS1-4,neosalpingostomy for symptomatic hydrosalpinx; 7) ovarian treatment for symptomatic ovarian pain; 8) uterosacral nerve vaporization for DYSMENORRHEA; 9) presacral neurectomy for disabling central PAIN primarily of uterine but also of bladder origin; 10) resection of endometriosis from all surfaces including removal from bladder and bowel as well as from the rectovaginal septal space.,PAIN,DYSMENORRHEA,RO-has_definitional_manifestation
503007640,7/14/2014 21:44:20,,1323120011,7/14/2014 21:44:00,neodev,0.6153,27597779,CAN,AB,Calgary,72.29.251.209,DYSMENORRHEA causes PAIN,196,136,,199,148,causes,0.811107105653813,904857-FS1-4,neosalpingostomy for symptomatic hydrosalpinx; 7) ovarian treatment for symptomatic ovarian pain; 8) uterosacral nerve vaporization for DYSMENORRHEA; 9) presacral neurectomy for disabling central PAIN primarily of uterine but also of bladder origin; 10) resection of endometriosis from all surfaces including removal from bladder and bowel as well as from the rectovaginal septal space.,PAIN,DYSMENORRHEA,RO-has_definitional_manifestation
503007640,7/14/2014 21:44:33,,1323120319,7/14/2014 21:44:25,prodege,0.5819,2143114,CAN,BC,Vancouver,24.84.160.12,DYSMENORRHEA causes PAIN,196,136,,199,148,causes,0.811107105653813,904857-FS1-4,neosalpingostomy for symptomatic hydrosalpinx; 7) ovarian treatment for symptomatic ovarian pain; 8) uterosacral nerve vaporization for DYSMENORRHEA; 9) presacral neurectomy for disabling central PAIN primarily of uterine but also of bladder origin; 10) resection of endometriosis from all surfaces including removal from bladder and bowel as well as from the rectovaginal septal space.,PAIN,DYSMENORRHEA,RO-has_definitional_manifestation
503007640,7/14/2014 21:50:10,,1323124013,7/14/2014 21:49:28,clixsense,0.5155,26889820,GBR,C3,Shelford,92.18.120.203,no_relation,196,136,,199,148,causes,0.811107105653813,904857-FS1-4,neosalpingostomy for symptomatic hydrosalpinx; 7) ovarian treatment for symptomatic ovarian pain; 8) uterosacral nerve vaporization for DYSMENORRHEA; 9) presacral neurectomy for disabling central PAIN primarily of uterine but also of bladder origin; 10) resection of endometriosis from all surfaces including removal from bladder and bowel as well as from the rectovaginal septal space.,PAIN,DYSMENORRHEA,RO-has_definitional_manifestation
503007641,7/14/2014 20:45:56,,1323088649,7/14/2014 20:45:52,instagc,0.6111,25990856,USA,NV,Las Vegas,68.108.98.78,no_relation,138,47,,142,76,is location of,0.960768922830523,905488-FS1-9,"HDGF was more highly expressed in the lungs of IDIOPATHIC PULMONARY FIBROSIS chiefly in the epithelial cells, than in control nonfibrotic LUNGS.",LUNGS,IDIOPATHIC PULMONARY FIBROSIS,RO-has_finding_site
503007641,7/14/2014 20:52:13,,1323091924,7/14/2014 20:51:31,clixsense,0.5,6574199,USA,TX,San Antonio,207.230.144.242,IDIOPATHIC PULMONARY FIBROSIS is location of LUNGS,138,47,,142,76,is location of,0.960768922830523,905488-FS1-9,"HDGF was more highly expressed in the lungs of IDIOPATHIC PULMONARY FIBROSIS chiefly in the epithelial cells, than in control nonfibrotic LUNGS.",LUNGS,IDIOPATHIC PULMONARY FIBROSIS,RO-has_finding_site
503007641,7/14/2014 21:33:15,,1323112465,7/14/2014 21:33:06,tremorgames,0.5903,28013393,USA,CA,Rancho Cordova,71.197.67.37,LUNGS is location of IDIOPATHIC PULMONARY FIBROSIS,138,47,,142,76,is location of,0.960768922830523,905488-FS1-9,"HDGF was more highly expressed in the lungs of IDIOPATHIC PULMONARY FIBROSIS chiefly in the epithelial cells, than in control nonfibrotic LUNGS.",LUNGS,IDIOPATHIC PULMONARY FIBROSIS,RO-has_finding_site
503007641,7/14/2014 21:37:20,,1323114753,7/14/2014 21:37:14,clixsense,0.4925,19162475,GBR,M3,Frome,82.33.126.30,LUNGS is location of IDIOPATHIC PULMONARY FIBROSIS,138,47,,142,76,is location of,0.960768922830523,905488-FS1-9,"HDGF was more highly expressed in the lungs of IDIOPATHIC PULMONARY FIBROSIS chiefly in the epithelial cells, than in control nonfibrotic LUNGS.",LUNGS,IDIOPATHIC PULMONARY FIBROSIS,RO-has_finding_site
503007641,7/14/2014 21:44:00,,1323119770,7/14/2014 21:43:12,instagc,0.6292,21551272,GBR,E6,Chipping Campden,78.145.193.123,LUNGS is location of IDIOPATHIC PULMONARY FIBROSIS,138,47,,142,76,is location of,0.960768922830523,905488-FS1-9,"HDGF was more highly expressed in the lungs of IDIOPATHIC PULMONARY FIBROSIS chiefly in the epithelial cells, than in control nonfibrotic LUNGS.",LUNGS,IDIOPATHIC PULMONARY FIBROSIS,RO-has_finding_site
503007641,7/14/2014 21:45:21,,1323120886,7/14/2014 21:45:11,prodege,0.5819,2143114,CAN,BC,Vancouver,24.84.160.12,IDIOPATHIC PULMONARY FIBROSIS is location of LUNGS,138,47,,142,76,is location of,0.960768922830523,905488-FS1-9,"HDGF was more highly expressed in the lungs of IDIOPATHIC PULMONARY FIBROSIS chiefly in the epithelial cells, than in control nonfibrotic LUNGS.",LUNGS,IDIOPATHIC PULMONARY FIBROSIS,RO-has_finding_site
503007641,7/14/2014 21:51:43,,1323124712,7/14/2014 21:51:01,clixsense,0.5155,26889820,GBR,C3,Shelford,92.18.120.203,no_relation,138,47,,142,76,is location of,0.960768922830523,905488-FS1-9,"HDGF was more highly expressed in the lungs of IDIOPATHIC PULMONARY FIBROSIS chiefly in the epithelial cells, than in control nonfibrotic LUNGS.",LUNGS,IDIOPATHIC PULMONARY FIBROSIS,RO-has_finding_site
503007642,7/14/2014 20:34:15,,1323082798,7/14/2014 20:33:57,clixsense,0.9583,27871219,NLD,07,Amsterdam,87.210.207.223,BONE is location of OSTEOMYELITIS,99,66,,102,79,is location of,0.824163383692134,902221-FS1-9,"In a 5 1/2 year retrospective study of hospitalized children with OSTEOMYELITIS who had technetium BONE scans, we found that 32 of 38 (84%) had increased radionuclide uptake, 4 (11%) had normal uptake and 2 (5%) had decreased uptake.",BONE,OSTEOMYELITIS,RO-disease_has_primary_anatomic_site
503007642,7/14/2014 20:49:01,,1323090218,7/14/2014 20:48:42,zoombucks,0.875,28232452,USA,NC,Cary,174.97.217.113,BONE is location of OSTEOMYELITIS,99,66,,102,79,is location of,0.824163383692134,902221-FS1-9,"In a 5 1/2 year retrospective study of hospitalized children with OSTEOMYELITIS who had technetium BONE scans, we found that 32 of 38 (84%) had increased radionuclide uptake, 4 (11%) had normal uptake and 2 (5%) had decreased uptake.",BONE,OSTEOMYELITIS,RO-disease_has_primary_anatomic_site
503007642,7/14/2014 21:37:40,,1323114958,7/14/2014 21:37:35,clixsense,0.4925,19162475,GBR,M3,Frome,82.33.126.30,OSTEOMYELITIS is location of BONE,99,66,,102,79,is location of,0.824163383692134,902221-FS1-9,"In a 5 1/2 year retrospective study of hospitalized children with OSTEOMYELITIS who had technetium BONE scans, we found that 32 of 38 (84%) had increased radionuclide uptake, 4 (11%) had normal uptake and 2 (5%) had decreased uptake.",BONE,OSTEOMYELITIS,RO-disease_has_primary_anatomic_site
503007642,7/14/2014 21:44:37,,1323120386,7/14/2014 21:44:21,neodev,0.6153,27597779,CAN,AB,Calgary,72.29.251.209,BONE is location of OSTEOMYELITIS,99,66,,102,79,is location of,0.824163383692134,902221-FS1-9,"In a 5 1/2 year retrospective study of hospitalized children with OSTEOMYELITIS who had technetium BONE scans, we found that 32 of 38 (84%) had increased radionuclide uptake, 4 (11%) had normal uptake and 2 (5%) had decreased uptake.",BONE,OSTEOMYELITIS,RO-disease_has_primary_anatomic_site
503007642,7/14/2014 21:47:46,,1323122691,7/14/2014 21:46:59,instagc,0.6292,21551272,GBR,E6,Chipping Campden,78.145.193.123,BONE is location of OSTEOMYELITIS,99,66,,102,79,is location of,0.824163383692134,902221-FS1-9,"In a 5 1/2 year retrospective study of hospitalized children with OSTEOMYELITIS who had technetium BONE scans, we found that 32 of 38 (84%) had increased radionuclide uptake, 4 (11%) had normal uptake and 2 (5%) had decreased uptake.",BONE,OSTEOMYELITIS,RO-disease_has_primary_anatomic_site
503007642,7/14/2014 22:28:28,,1323145365,7/14/2014 22:28:13,clixsense,0.5752,15189335,GBR,K3,Peterborough,81.156.166.189,BONE is location of OSTEOMYELITIS,99,66,,102,79,is location of,0.824163383692134,902221-FS1-9,"In a 5 1/2 year retrospective study of hospitalized children with OSTEOMYELITIS who had technetium BONE scans, we found that 32 of 38 (84%) had increased radionuclide uptake, 4 (11%) had normal uptake and 2 (5%) had decreased uptake.",BONE,OSTEOMYELITIS,RO-disease_has_primary_anatomic_site
503007642,7/14/2014 22:32:20,,1323147017,7/14/2014 22:32:15,clixsense,0.3016,25419319,GBR,H8,Liverpool,94.4.192.228,OSTEOMYELITIS is location of BONE,99,66,,102,79,is location of,0.824163383692134,902221-FS1-9,"In a 5 1/2 year retrospective study of hospitalized children with OSTEOMYELITIS who had technetium BONE scans, we found that 32 of 38 (84%) had increased radionuclide uptake, 4 (11%) had normal uptake and 2 (5%) had decreased uptake.",BONE,OSTEOMYELITIS,RO-disease_has_primary_anatomic_site
503007643,7/14/2014 20:34:42,,1323082998,7/14/2014 20:34:17,clixsense,0.9583,27871219,NLD,07,Amsterdam,87.210.207.223,OSTEOMYELITIS diagnosed by BONE,99,66,,102,79,diagnosed by,0.549442255794756,902221-FS1-13,"In a 5 1/2 year retrospective study of hospitalized children with OSTEOMYELITIS who had technetium BONE scans, we found that 32 of 38 (84%) had increased radionuclide uptake, 4 (11%) had normal uptake and 2 (5%) had decreased uptake.",BONE,OSTEOMYELITIS,RO-disease_has_primary_anatomic_site
503007643,7/14/2014 21:13:47,,1323102830,7/14/2014 21:13:10,elite,0.8694,28276268,USA,MI,Taylor,67.149.247.166,OSTEOMYELITIS diagnosed by BONE,99,66,,102,79,diagnosed by,0.549442255794756,902221-FS1-13,"In a 5 1/2 year retrospective study of hospitalized children with OSTEOMYELITIS who had technetium BONE scans, we found that 32 of 38 (84%) had increased radionuclide uptake, 4 (11%) had normal uptake and 2 (5%) had decreased uptake.",BONE,OSTEOMYELITIS,RO-disease_has_primary_anatomic_site
503007643,7/14/2014 21:23:49,,1323107337,7/14/2014 21:23:38,clixsense,0.5625,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,99,66,,102,79,diagnosed by,0.549442255794756,902221-FS1-13,"In a 5 1/2 year retrospective study of hospitalized children with OSTEOMYELITIS who had technetium BONE scans, we found that 32 of 38 (84%) had increased radionuclide uptake, 4 (11%) had normal uptake and 2 (5%) had decreased uptake.",BONE,OSTEOMYELITIS,RO-disease_has_primary_anatomic_site
503007643,7/14/2014 21:37:26,,1323114840,7/14/2014 21:37:22,clixsense,0.4925,19162475,GBR,M3,Frome,82.33.126.30,OSTEOMYELITIS diagnosed by BONE,99,66,,102,79,diagnosed by,0.549442255794756,902221-FS1-13,"In a 5 1/2 year retrospective study of hospitalized children with OSTEOMYELITIS who had technetium BONE scans, we found that 32 of 38 (84%) had increased radionuclide uptake, 4 (11%) had normal uptake and 2 (5%) had decreased uptake.",BONE,OSTEOMYELITIS,RO-disease_has_primary_anatomic_site
503007643,7/14/2014 21:37:54,,1323115125,7/14/2014 21:37:30,clixsense,0.5974,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,99,66,,102,79,diagnosed by,0.549442255794756,902221-FS1-13,"In a 5 1/2 year retrospective study of hospitalized children with OSTEOMYELITIS who had technetium BONE scans, we found that 32 of 38 (84%) had increased radionuclide uptake, 4 (11%) had normal uptake and 2 (5%) had decreased uptake.",BONE,OSTEOMYELITIS,RO-disease_has_primary_anatomic_site
503007643,7/14/2014 21:44:48,,1323120491,7/14/2014 21:44:34,prodege,0.5819,2143114,CAN,BC,Vancouver,24.84.160.12,BONE diagnosed by OSTEOMYELITIS,99,66,,102,79,diagnosed by,0.549442255794756,902221-FS1-13,"In a 5 1/2 year retrospective study of hospitalized children with OSTEOMYELITIS who had technetium BONE scans, we found that 32 of 38 (84%) had increased radionuclide uptake, 4 (11%) had normal uptake and 2 (5%) had decreased uptake.",BONE,OSTEOMYELITIS,RO-disease_has_primary_anatomic_site
503007643,7/14/2014 22:30:44,,1323146298,7/14/2014 22:29:58,clixsense,0.5752,15189335,GBR,K3,Peterborough,81.156.166.189,no_relation,99,66,,102,79,diagnosed by,0.549442255794756,902221-FS1-13,"In a 5 1/2 year retrospective study of hospitalized children with OSTEOMYELITIS who had technetium BONE scans, we found that 32 of 38 (84%) had increased radionuclide uptake, 4 (11%) had normal uptake and 2 (5%) had decreased uptake.",BONE,OSTEOMYELITIS,RO-disease_has_primary_anatomic_site
503007644,7/14/2014 20:34:29,,1323082911,7/14/2014 20:34:11,neodev,0.9583,21515166,NLD,11,Nootdorp,83.86.58.179,ALBUTEROL treats ASTHMA,181,201,,186,210,treats,0.970725343394151,907668-FS1-2,"CONCLUSION  In mild asthma, patients with the Gly/Gly genotype had better asthma control with albuterol than when it was withdrawn, and patients with the Arg/Arg genotype had worse ASTHMA control with ALBUTEROL than when it was withdrawn.",ASTHMA,ALBUTEROL,RO-may_treat
503007644,7/14/2014 20:42:56,,1323087146,7/14/2014 20:42:41,elite,0.875,28503042,USA,NJ,Woodbridge,54.191.150.115,ASTHMA treats ALBUTEROL,181,201,,186,210,treats,0.970725343394151,907668-FS1-2,"CONCLUSION  In mild asthma, patients with the Gly/Gly genotype had better asthma control with albuterol than when it was withdrawn, and patients with the Arg/Arg genotype had worse ASTHMA control with ALBUTEROL than when it was withdrawn.",ASTHMA,ALBUTEROL,RO-may_treat
503007644,7/14/2014 20:49:38,,1323090595,7/14/2014 20:49:23,zoombucks,0.875,28232452,USA,NC,Cary,174.97.217.113,ALBUTEROL treats ASTHMA,181,201,,186,210,treats,0.970725343394151,907668-FS1-2,"CONCLUSION  In mild asthma, patients with the Gly/Gly genotype had better asthma control with albuterol than when it was withdrawn, and patients with the Arg/Arg genotype had worse ASTHMA control with ALBUTEROL than when it was withdrawn.",ASTHMA,ALBUTEROL,RO-may_treat
503007644,7/14/2014 21:23:37,,1323107252,7/14/2014 21:23:27,clixsense,0.5625,16827630,GBR,A7,Birmingham,86.146.169.103,ALBUTEROL treats ASTHMA,181,201,,186,210,treats,0.970725343394151,907668-FS1-2,"CONCLUSION  In mild asthma, patients with the Gly/Gly genotype had better asthma control with albuterol than when it was withdrawn, and patients with the Arg/Arg genotype had worse ASTHMA control with ALBUTEROL than when it was withdrawn.",ASTHMA,ALBUTEROL,RO-may_treat
503007644,7/14/2014 21:26:16,,1323108638,7/14/2014 21:26:06,prodege,0.7306,23541832,USA,AZ,Tempe,149.169.129.225,ALBUTEROL treats ASTHMA,181,201,,186,210,treats,0.970725343394151,907668-FS1-2,"CONCLUSION  In mild asthma, patients with the Gly/Gly genotype had better asthma control with albuterol than when it was withdrawn, and patients with the Arg/Arg genotype had worse ASTHMA control with ALBUTEROL than when it was withdrawn.",ASTHMA,ALBUTEROL,RO-may_treat
503007644,7/14/2014 21:31:50,,1323111738,7/14/2014 21:31:15,instagc,0.6498,19602039,USA,WA,Bellevue,50.135.214.140,ALBUTEROL treats ASTHMA,181,201,,186,210,treats,0.970725343394151,907668-FS1-2,"CONCLUSION  In mild asthma, patients with the Gly/Gly genotype had better asthma control with albuterol than when it was withdrawn, and patients with the Arg/Arg genotype had worse ASTHMA control with ALBUTEROL than when it was withdrawn.",ASTHMA,ALBUTEROL,RO-may_treat
503007644,7/14/2014 21:35:15,,1323113557,7/14/2014 21:34:23,neodev,0.7333,18755947,GBR,H2,Accrington,80.47.185.52,ALBUTEROL treats ASTHMA,181,201,,186,210,treats,0.970725343394151,907668-FS1-2,"CONCLUSION  In mild asthma, patients with the Gly/Gly genotype had better asthma control with albuterol than when it was withdrawn, and patients with the Arg/Arg genotype had worse ASTHMA control with ALBUTEROL than when it was withdrawn.",ASTHMA,ALBUTEROL,RO-may_treat
503007645,7/14/2014 20:49:01,,1323090216,7/14/2014 20:48:42,zoombucks,0.875,28232452,USA,NC,Cary,174.97.217.113,OVARIAN MUCINOUS ADENOCARCINOMAS diagnosed by ASCITES,141,63,,147,95,diagnosed by,0.353553390593274,902909-FS1-13,"On cytology it was found that cancer cells in the ascites from OVARIAN MUCINOUS ADENOCARCINOMAS were HNF4 alpha positive, but tumor cells in ASCITES from other types of ovarian carcinomas were negative for HNF4 alpha.",ASCITES,OVARIAN MUCINOUS ADENOCARCINOMAS,RO-disease_may_have_finding
503007645,7/14/2014 21:24:01,,1323107436,7/14/2014 21:23:50,clixsense,0.5625,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,141,63,,147,95,diagnosed by,0.353553390593274,902909-FS1-13,"On cytology it was found that cancer cells in the ascites from OVARIAN MUCINOUS ADENOCARCINOMAS were HNF4 alpha positive, but tumor cells in ASCITES from other types of ovarian carcinomas were negative for HNF4 alpha.",ASCITES,OVARIAN MUCINOUS ADENOCARCINOMAS,RO-disease_may_have_finding
503007645,7/14/2014 21:32:44,,1323112194,7/14/2014 21:32:22,tremorgames,0.5903,28013393,USA,CA,Rancho Cordova,71.197.67.37,OVARIAN MUCINOUS ADENOCARCINOMAS diagnosed by ASCITES,141,63,,147,95,diagnosed by,0.353553390593274,902909-FS1-13,"On cytology it was found that cancer cells in the ascites from OVARIAN MUCINOUS ADENOCARCINOMAS were HNF4 alpha positive, but tumor cells in ASCITES from other types of ovarian carcinomas were negative for HNF4 alpha.",ASCITES,OVARIAN MUCINOUS ADENOCARCINOMAS,RO-disease_may_have_finding
503007645,7/14/2014 21:37:13,,1323114653,7/14/2014 21:37:07,clixsense,0.4925,19162475,GBR,M3,Frome,82.33.126.30,ASCITES diagnosed by OVARIAN MUCINOUS ADENOCARCINOMAS,141,63,,147,95,diagnosed by,0.353553390593274,902909-FS1-13,"On cytology it was found that cancer cells in the ascites from OVARIAN MUCINOUS ADENOCARCINOMAS were HNF4 alpha positive, but tumor cells in ASCITES from other types of ovarian carcinomas were negative for HNF4 alpha.",ASCITES,OVARIAN MUCINOUS ADENOCARCINOMAS,RO-disease_may_have_finding
503007645,7/14/2014 21:45:01,,1323120636,7/14/2014 21:44:49,prodege,0.5819,2143114,CAN,BC,Vancouver,24.84.160.12,OVARIAN MUCINOUS ADENOCARCINOMAS diagnosed by ASCITES,141,63,,147,95,diagnosed by,0.353553390593274,902909-FS1-13,"On cytology it was found that cancer cells in the ascites from OVARIAN MUCINOUS ADENOCARCINOMAS were HNF4 alpha positive, but tumor cells in ASCITES from other types of ovarian carcinomas were negative for HNF4 alpha.",ASCITES,OVARIAN MUCINOUS ADENOCARCINOMAS,RO-disease_may_have_finding
503007645,7/14/2014 22:08:26,,1323133039,7/14/2014 22:08:08,instagc,0.5915,18960682,GBR,"","",86.29.147.112,OVARIAN MUCINOUS ADENOCARCINOMAS diagnosed by ASCITES,141,63,,147,95,diagnosed by,0.353553390593274,902909-FS1-13,"On cytology it was found that cancer cells in the ascites from OVARIAN MUCINOUS ADENOCARCINOMAS were HNF4 alpha positive, but tumor cells in ASCITES from other types of ovarian carcinomas were negative for HNF4 alpha.",ASCITES,OVARIAN MUCINOUS ADENOCARCINOMAS,RO-disease_may_have_finding
503007645,7/14/2014 22:31:13,,1323146516,7/14/2014 22:30:48,instagc,0.5867,23149109,USA,NC,Durham,75.189.206.205,OVARIAN MUCINOUS ADENOCARCINOMAS diagnosed by ASCITES,141,63,,147,95,diagnosed by,0.353553390593274,902909-FS1-13,"On cytology it was found that cancer cells in the ascites from OVARIAN MUCINOUS ADENOCARCINOMAS were HNF4 alpha positive, but tumor cells in ASCITES from other types of ovarian carcinomas were negative for HNF4 alpha.",ASCITES,OVARIAN MUCINOUS ADENOCARCINOMAS,RO-disease_may_have_finding
503007646,7/14/2014 20:33:25,,1323082413,7/14/2014 20:33:07,clixsense,0.9583,27871219,NLD,07,Amsterdam,87.210.207.223,CLINDAMYCIN treats SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS,98,66,,135,77,treats,0.987878339907213,907658-FS1-2,161  For pyrimethamine dosages of 25 50 mg once daily (given with CLINDAMYCIN or sulfadiazine for SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS): 10 25 mg once daily.,SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS,CLINDAMYCIN,RO-may_treat
503007646,7/14/2014 20:46:00,,1323088699,7/14/2014 20:45:57,instagc,0.6111,25990856,USA,NV,Las Vegas,68.108.98.78,SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS treats CLINDAMYCIN,98,66,,135,77,treats,0.987878339907213,907658-FS1-2,161  For pyrimethamine dosages of 25 50 mg once daily (given with CLINDAMYCIN or sulfadiazine for SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS): 10 25 mg once daily.,SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS,CLINDAMYCIN,RO-may_treat
503007646,7/14/2014 21:32:05,,1323111858,7/14/2014 21:31:40,tremorgames,0.5903,28013393,USA,CA,Rancho Cordova,71.197.67.37,CLINDAMYCIN treats SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS,98,66,,135,77,treats,0.987878339907213,907658-FS1-2,161  For pyrimethamine dosages of 25 50 mg once daily (given with CLINDAMYCIN or sulfadiazine for SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS): 10 25 mg once daily.,SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS,CLINDAMYCIN,RO-may_treat
503007646,7/14/2014 21:40:55,,1323117315,7/14/2014 21:40:18,instagc,0.7958,28301350,GBR,K4,Plymouth,92.28.215.248,CLINDAMYCIN treats SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS,98,66,,135,77,treats,0.987878339907213,907658-FS1-2,161  For pyrimethamine dosages of 25 50 mg once daily (given with CLINDAMYCIN or sulfadiazine for SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS): 10 25 mg once daily.,SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS,CLINDAMYCIN,RO-may_treat
503007646,7/14/2014 21:44:00,,1323119783,7/14/2014 21:43:12,instagc,0.6292,21551272,GBR,E6,Chipping Campden,78.145.193.123,CLINDAMYCIN treats SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS,98,66,,135,77,treats,0.987878339907213,907658-FS1-2,161  For pyrimethamine dosages of 25 50 mg once daily (given with CLINDAMYCIN or sulfadiazine for SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS): 10 25 mg once daily.,SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS,CLINDAMYCIN,RO-may_treat
503007646,7/14/2014 21:44:48,,1323120526,7/14/2014 21:44:34,prodege,0.5819,2143114,CAN,BC,Vancouver,24.84.160.12,CLINDAMYCIN treats SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS,98,66,,135,77,treats,0.987878339907213,907658-FS1-2,161  For pyrimethamine dosages of 25 50 mg once daily (given with CLINDAMYCIN or sulfadiazine for SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS): 10 25 mg once daily.,SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS,CLINDAMYCIN,RO-may_treat
503007646,7/14/2014 22:29:55,,1323145979,7/14/2014 22:29:20,clixsense,0.5752,15189335,GBR,K3,Peterborough,81.156.166.189,CLINDAMYCIN treats SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS,98,66,,135,77,treats,0.987878339907213,907658-FS1-2,161  For pyrimethamine dosages of 25 50 mg once daily (given with CLINDAMYCIN or sulfadiazine for SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS): 10 25 mg once daily.,SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS,CLINDAMYCIN,RO-may_treat
503007647,7/14/2014 20:34:46,,1323083030,7/14/2014 20:34:31,neodev,0.9583,21515166,NLD,11,Nootdorp,83.86.58.179,TRIGEMINAL NEURALGIA causes PAIN,21,71,,24,91,causes,0.993883734673619,904802-FS1-4,Predictive model for PAIN recurrence after posterior fossa surgery for TRIGEMINAL NEURALGIA,PAIN,TRIGEMINAL NEURALGIA,RO-has_definitional_manifestation
503007647,7/14/2014 20:48:41,,1323090057,7/14/2014 20:48:21,zoombucks,0.875,28232452,USA,NC,Cary,174.97.217.113,TRIGEMINAL NEURALGIA causes PAIN,21,71,,24,91,causes,0.993883734673619,904802-FS1-4,Predictive model for PAIN recurrence after posterior fossa surgery for TRIGEMINAL NEURALGIA,PAIN,TRIGEMINAL NEURALGIA,RO-has_definitional_manifestation
503007647,7/14/2014 21:15:25,,1323103659,7/14/2014 21:14:40,prodege,0.7639,28255346,GBR,L9,Sheffield,2.125.183.137,TRIGEMINAL NEURALGIA causes PAIN,21,71,,24,91,causes,0.993883734673619,904802-FS1-4,Predictive model for PAIN recurrence after posterior fossa surgery for TRIGEMINAL NEURALGIA,PAIN,TRIGEMINAL NEURALGIA,RO-has_definitional_manifestation
503007647,7/14/2014 21:23:27,,1323107192,7/14/2014 21:23:12,clixsense,0.5625,16827630,GBR,A7,Birmingham,86.146.169.103,TRIGEMINAL NEURALGIA causes PAIN,21,71,,24,91,causes,0.993883734673619,904802-FS1-4,Predictive model for PAIN recurrence after posterior fossa surgery for TRIGEMINAL NEURALGIA,PAIN,TRIGEMINAL NEURALGIA,RO-has_definitional_manifestation
503007647,7/14/2014 21:27:02,,1323109030,7/14/2014 21:26:43,prodege,0.7306,23541832,USA,AZ,Tempe,149.169.129.225,TRIGEMINAL NEURALGIA causes PAIN,21,71,,24,91,causes,0.993883734673619,904802-FS1-4,Predictive model for PAIN recurrence after posterior fossa surgery for TRIGEMINAL NEURALGIA,PAIN,TRIGEMINAL NEURALGIA,RO-has_definitional_manifestation
503007647,7/14/2014 21:31:50,,1323111737,7/14/2014 21:31:15,instagc,0.6498,19602039,USA,WA,Bellevue,50.135.214.140,TRIGEMINAL NEURALGIA causes PAIN,21,71,,24,91,causes,0.993883734673619,904802-FS1-4,Predictive model for PAIN recurrence after posterior fossa surgery for TRIGEMINAL NEURALGIA,PAIN,TRIGEMINAL NEURALGIA,RO-has_definitional_manifestation
503007647,7/14/2014 21:36:40,,1323114381,7/14/2014 21:36:19,clixsense,0.5974,19803139,NLD,06,Veldhoven,212.61.84.196,TRIGEMINAL NEURALGIA causes PAIN,21,71,,24,91,causes,0.993883734673619,904802-FS1-4,Predictive model for PAIN recurrence after posterior fossa surgery for TRIGEMINAL NEURALGIA,PAIN,TRIGEMINAL NEURALGIA,RO-has_definitional_manifestation
503007648,7/14/2014 21:12:13,,1323102226,7/14/2014 21:11:28,elite,0.8694,28276268,USA,MI,Taylor,67.149.247.166,PERSISTENT UNEXPLAINED PAIN causes OSTEOID OSTEOMA OF THE STYLOID,36,133,,62,163,causes,0.970142500145332,901842-FS1-4,"It is suggested that in any case of PERSISTENT UNEXPLAINED PAIN of the wrist or clinical symptoms resembling those of tenosynovitis, OSTEOID OSTEOMA OF THE STYLOID process of the radius or of the carpal bones should also be included in the differential diagnosis.",PERSISTENT UNEXPLAINED PAIN,OSTEOID OSTEOMA OF THE STYLOID,RO-disease_has_finding
503007648,7/14/2014 21:16:27,,1323104131,7/14/2014 21:15:27,prodege,0.7639,28255346,GBR,L9,Sheffield,2.125.183.137,no_relation,36,133,,62,163,causes,0.970142500145332,901842-FS1-4,"It is suggested that in any case of PERSISTENT UNEXPLAINED PAIN of the wrist or clinical symptoms resembling those of tenosynovitis, OSTEOID OSTEOMA OF THE STYLOID process of the radius or of the carpal bones should also be included in the differential diagnosis.",PERSISTENT UNEXPLAINED PAIN,OSTEOID OSTEOMA OF THE STYLOID,RO-disease_has_finding
503007648,7/14/2014 21:44:33,,1323120277,7/14/2014 21:44:25,prodege,0.5819,2143114,CAN,BC,Vancouver,24.84.160.12,OSTEOID OSTEOMA OF THE STYLOID causes PERSISTENT UNEXPLAINED PAIN,36,133,,62,163,causes,0.970142500145332,901842-FS1-4,"It is suggested that in any case of PERSISTENT UNEXPLAINED PAIN of the wrist or clinical symptoms resembling those of tenosynovitis, OSTEOID OSTEOMA OF THE STYLOID process of the radius or of the carpal bones should also be included in the differential diagnosis.",PERSISTENT UNEXPLAINED PAIN,OSTEOID OSTEOMA OF THE STYLOID,RO-disease_has_finding
503007648,7/14/2014 21:45:22,,1323120911,7/14/2014 21:44:38,neodev,0.6153,27597779,CAN,AB,Calgary,72.29.251.209,no_relation,36,133,,62,163,causes,0.970142500145332,901842-FS1-4,"It is suggested that in any case of PERSISTENT UNEXPLAINED PAIN of the wrist or clinical symptoms resembling those of tenosynovitis, OSTEOID OSTEOMA OF THE STYLOID process of the radius or of the carpal bones should also be included in the differential diagnosis.",PERSISTENT UNEXPLAINED PAIN,OSTEOID OSTEOMA OF THE STYLOID,RO-disease_has_finding
503007648,7/14/2014 22:08:43,,1323133161,7/14/2014 22:08:27,instagc,0.5915,18960682,GBR,"","",86.29.147.112,OSTEOID OSTEOMA OF THE STYLOID causes PERSISTENT UNEXPLAINED PAIN,36,133,,62,163,causes,0.970142500145332,901842-FS1-4,"It is suggested that in any case of PERSISTENT UNEXPLAINED PAIN of the wrist or clinical symptoms resembling those of tenosynovitis, OSTEOID OSTEOMA OF THE STYLOID process of the radius or of the carpal bones should also be included in the differential diagnosis.",PERSISTENT UNEXPLAINED PAIN,OSTEOID OSTEOMA OF THE STYLOID,RO-disease_has_finding
503007648,7/14/2014 22:30:29,,1323146178,7/14/2014 22:30:06,instagc,0.5867,23149109,USA,NC,Durham,75.189.206.205,OSTEOID OSTEOMA OF THE STYLOID causes PERSISTENT UNEXPLAINED PAIN,36,133,,62,163,causes,0.970142500145332,901842-FS1-4,"It is suggested that in any case of PERSISTENT UNEXPLAINED PAIN of the wrist or clinical symptoms resembling those of tenosynovitis, OSTEOID OSTEOMA OF THE STYLOID process of the radius or of the carpal bones should also be included in the differential diagnosis.",PERSISTENT UNEXPLAINED PAIN,OSTEOID OSTEOMA OF THE STYLOID,RO-disease_has_finding
503007648,7/14/2014 22:32:32,,1323147102,7/14/2014 22:32:27,clixsense,0.3016,25419319,GBR,H8,Liverpool,94.4.192.228,PERSISTENT UNEXPLAINED PAIN causes OSTEOID OSTEOMA OF THE STYLOID,36,133,,62,163,causes,0.970142500145332,901842-FS1-4,"It is suggested that in any case of PERSISTENT UNEXPLAINED PAIN of the wrist or clinical symptoms resembling those of tenosynovitis, OSTEOID OSTEOMA OF THE STYLOID process of the radius or of the carpal bones should also be included in the differential diagnosis.",PERSISTENT UNEXPLAINED PAIN,OSTEOID OSTEOMA OF THE STYLOID,RO-disease_has_finding
